| Details |
title |
year |
| Details |
#198 MUC13 promotes pancreatic tumor-stromal interactions by influ- encing ... |
2018 |
| Details |
#457 Protein and chemotherapy profling of extracellular vesicles har- veste... |
2018 |
| Details |
T cells me- diated anticancer effect though TLR4 signaling of dendritic ce... |
2018 |
| Details |
#977 Glycosylation of estrogen receptor alpha by N-acetylgalactosaminyl- tr... |
2018 |
| Details |
#1237 CancerriskinmyotonicdystrophytypeI:Firstevidenceofarolefor disease se... |
2018 |
| Details |
#1503 Arsenic trioxide inhibits proliferation of acute leukemia cells throu... |
2018 |
| Details |
#1761 Combination of a T cell activating immunotherapy with immune modulato... |
2018 |
| Details |
TUMOR BIOLOGY: Epithelial Cancer Stem Cell Biology... |
2018 |
| Details |
#2270 Integrating 5hmC and gene expression data infers regulatory mechanism... |
2018 |
| Details |
#2527 Regulation of mitotic progression in T-cell acute lymphoblastic leuke... |
2018 |
| Details |
#2788 VB6-845d tumor cell killing elicits biologic features of immuno- geni... |
2018 |
| Details |
#3039 Role of IDH mutation status on molecular and spatial heterogene- ity ... |
2018 |
| Details |
#3297 A tyrosine kinase interactome reveals network states that guide the u... |
2018 |
| Details |
#3557 Beta-hydroxybutyrate inhibits oncogenic signaling and cellular motili... |
2018 |
| Details |
#3803 ImmuneescapefromNKcellsandactivatedCD8TcellsbymiR-183 repression of M... |
2018 |
| Details |
#4062 Novel synthetic peptide targets CD206 receptor promoting the re- pola... |
2018 |
| Details |
#4312 3-Hydroxyterphenyllin induces S phase arrest in ovarian cancer cells.... |
2018 |
| Details |
CLINICAL RESEARCH: Liquid Biopsy 4 #4574 Detection of minimal residual dise... |
2018 |
| Details |
#4838 R loop-driven genome instability by G-quadruplex binders in BRCA2-sil... |
2018 |
| Details |
#5098 Conditional ERK3 overexpression and PTEN deletion induce lung tumors ... |
2018 |
| Details |
#5365 Prospective patient stratifcation into robust cancer-cell intrinsic s... |
2018 |
| Details |
#5626 Preclinical characterization of Sym022, a novel anti-LAG3 anti- body.... |
2018 |
| Details |
#5885 Loss of RAD51C promoter hypermethylation confers PARP inhib- itor r... |
2018 |
| Details |
#199 Host CYP27A1 expression is essential for ovarian cancer progres- sion.... |
2018 |
| Details |
#458 Relationship between autophagy, activation and senescence in nor- mal ... |
2018 |
| Details |
#723 Targeting phosphorylated p53 to elicit tumor-reactive T helper re- spo... |
2018 |
| Details |
MULTIDISCIPLINARY: Radiation Science #978 In vivo shRNA screening identifes... |
2018 |
| Details |
#1238 International comparison of cancer risks for Lynch syndrome.... |
2018 |
| Details |
#1504 Opposing roles of FoxM1 and the hepatic specifcation genes FoxA1/A2 d... |
2018 |
| Details |
#1762 Shifting the tumor microenvironment with frst-in-class sema- phorin 4... |
2018 |
| Details |
#2009 Breast cancer stem cells are associated with HER2-mediated radio- res... |
2018 |
| Details |
#2271 Pathway analysis suggests biological processes driven by germline gen... |
2018 |
| Details |
#2528 Determining gene expression variability between in vitro and in vi... |
2018 |
| Details |
#2789 Development of highly potent T-cell receptor bispecifcs with pico- mo... |
2018 |
| Details |
#3040 Radiomics discriminates pseudo-progression from true progres- sion in... |
2018 |
| Details |
#3298 High-content phenotyping of somatic cancer mutations by func- tional ... |
2018 |
| Details |
B activation .... |
2018 |
| Details |
#3805 Expression of tryptophan -2, 3-dioxygense (TDO) in metastatic uveal m... |
2018 |
| Details |
#4063 Target immunosuppressive myeloid cells to enhance cancer immu- nother... |
2018 |
| Details |
MOLECULAR AND CELLULAR BIOLOGY / GENETICS: Epigenomics #4313 Methylated BAF... |
2018 |
| Details |
#4575 Effcient and accurate NGS approach for liquid biopsy detection and mo... |
2018 |
| Details |
#4839 Targeting glioma stem cells by pharmacologic stabilization of G- quad... |
2018 |
| Details |
#5099 Evaluating Ago2 as an oncogene in Kras-dependent lung carci- noma.... |
2018 |
| Details |
#5367 Elucidating the factors determining P53 binding and transcrip- tomic ... |
2018 |
| Details |
#5627 Anti-TIGIT biomarker study: Inhibition of TIGIT induces loss of Tregs... |
2018 |
| Details |
#5886 Translational reprogramming of breast cancer and its role in ta- moxi... |
2018 |
| Details |
#200 FOXD1 promotes stromal investment in clear cell renal cell carci- noma... |
2018 |
| Details |
#459 Therapy-induced senescence is reversible in vitro and in vivo.... |
2018 |
| Details |
#724 A novel heterologous prime boost vaccine system drives tumor spe- cifc... |
2018 |
| Details |
#979 EGLN inhibition reduces gastrointestinal radiation toxicity and im- pr... |
2018 |
| Details |
#1239 Risk of pancreatic cancer is increased among frst-degree relatives of... |
2018 |
| Details |
#1505 GATA3 expression is associated with poor differentiation of osteo- sa... |
2018 |
| Details |
#1762A CD200 and CD200R1 expressions and their prognostic roles in patients... |
2018 |
| Details |
#2010 Aggressive features of gastrointestinal melanoma as compared to skin ... |
2018 |
| Details |
#2272 Identifcation of predictive biomarkers for immunotherapy of brain and... |
2018 |
| Details |
#2529 GENT 2.0, a newly updated database: Gene expression across nor- mal a... |
2018 |
| Details |
and inhibits the growth of syngeneic tu- mors in combination with anti-PD1... |
2018 |
| Details |
#3041 Molecular, histopathologic, MRI and PET fndings in syngeneic oncologi... |
2018 |
| Details |
#3299 High-throughput combinatorial CRISPR-Cas9 gene knockout re- veals mos... |
2018 |
| Details |
#3560 Targeting the MIF receptor CD74 in bladder cancer tumorigenesis.... |
2018 |
| Details |
#3806 The pattern of NKG2DL expressions determines immunogenicity and antit... |
2018 |
| Details |
#4064 Spatial re-distribution of natural killer cells targets drug resistan... |
2018 |
| Details |
#4314 Chromatin state alterations during melanoma progression.... |
2018 |
| Details |
#4576 Combination of a label independent CTC enrichment platform with fluor... |
2018 |
| Details |
#4840 APTO-253 is a new addition to the repertoire of drugs that can exploi... |
2018 |
| Details |
#5101 Characterization of a mouse model using the Sleeping Beauty transposo... |
2018 |
| Details |
MOLECULAR AND CELLULAR BIOLOGY / GENETICS: Genomic Profling of Tumors 5 #53... |
2018 |
| Details |
target cells.... |
2018 |
| Details |
#5887 A microRNA signature panel predicts differential sensitivity of liver... |
2018 |
| Details |
TUMOR BIOLOGY: Tumor Heterogeneity 1 #201 Multiregion joint somatic genotyp... |
2018 |
| Details |
#460 Reversibility of chemotherapy-induced senescence in breast tumor cells... |
2018 |
| Details |
#725 Targeting the skin microenvironment for effective cancer vaccines.... |
2018 |
| Details |
#980 Molecular basis of adipose-derived stem cell (ASCs) therapy for manage... |
2018 |
| Details |
#1240 Comprehensive analysis of germline variants in Mexican patients with ... |
2018 |
| Details |
#1506 Characterization of fbronectin type III domain containing 3B (FNDC3B)... |
2018 |
| Details |
brain tumor initiating cells using immunotherapy-based treatment strategie... |
2018 |
| Details |
#2011 Expression analysis of transcribed-ultraconserved regions in can- cer... |
2018 |
| Details |
#2273 Meta-analysis of cancer cell lines based on responses to Tumor Treati... |
2018 |
| Details |
#2530 An analysis of correlative interactions between Plk1, Notch1 and FoxM... |
2018 |
| Details |
#2791 Physiologically based pharmacokinetic modeling and simulations to est... |
2018 |
| Details |
#3042 Nuclear morphology predicts prostate cancer metastasis at diagno- sis... |
2018 |
| Details |
#3300 Network analysis of the human protein-protein interactome: Tu- morige... |
2018 |
| Details |
#3561 Functional expression of BK channel subunits in LNCaP prostate cancer... |
2018 |
| Details |
#3808 Interrogation and modulation of the immunosuppressive activity of hum... |
2018 |
| Details |
#4065 Suppression of myeloid cell arginase activity leads to therapeutic re... |
2018 |
| Details |
#4315 Colorectal cancer epigenomic landscape.... |
2018 |
| Details |
#4577 ESR1 methylation: A liquid biopsy-based epigenetic assay for the foll... |
2018 |
| Details |
#4841 Prostate cancer cell death triggered by a small molecule interacting ... |
2018 |
| Details |
#5102 Identifying relevant mouse models of human cancer using the mouse tum... |
2018 |
| Details |
#5369 Tumorigenesis in Lynch syndrome: Somatic mutation profles compared to... |
2018 |
| Details |
#5629 Preclinical characterization of Sym023 a human anti-TIM3 anti- body w... |
2018 |
| Details |
#5888 Disruption of FOXO3a-miRNAs mediated feedback inhibition of IGF2-IRS1... |
2018 |
| Details |
#203 Regenerable altruism drives chemotolerance in clonal cancer cells.... |
2018 |
| Details |
#461 An essential role of the iron-sulfur cluster assembly enzyme isu-1 in ... |
2018 |
| Details |
-antigen vaccine in the B16F10 mouse model.... |
2018 |
| Details |
#981 Wee-1 kinase inhibitor AZD-1775 radiosensitizes esophageal cancer thro... |
2018 |
| Details |
#1241 Profle of BRCA1/BRCA2 mutations in Russian ovarian cancer population ... |
2018 |
| Details |
#1507 Multiple mechanisms of Myb gene activation revealed through transcrip... |
2018 |
| Details |
#1763A Single-cell RNA-sequencing reveals the immune contexture of triple-n... |
2018 |
| Details |
TUMOR BIOLOGY: Epithelial-to-Mesenchymal Transition and EMT and TGFbeta in ... |
2018 |
| Details |
BIOINFORMATICS AND SYSTEMS BIOLOGY: New Software for Data Analysis #2274 Ca... |
2018 |
| Details |
#2531 Diagnostic evaluation of indeterminate pulmonary nodules via rna-seq ... |
2018 |
| Details |
#2792 The combination of immune checkpoint blockers with the anti- ICOS KY1... |
2018 |
| Details |
#3043 Quantitative MRI during neoadjuvant therapy for predicting breast can... |
2018 |
| Details |
#3301 Using a novel single-cell lineage-tracing technique to uncover the me... |
2018 |
| Details |
#3562 Merkel cell polyomavirus t-antigen regulates aggresome formation and ... |
2018 |
| Details |
#3809 T-cell activation through the inhibition of tumor-expressed IDO1 acti... |
2018 |
| Details |
#4066 AnnexinV: Multifunctional anticancer immunotherapeutic pro- tein in t... |
2018 |
| Details |
#4316 Disruption and restoration of pioneer transcription factor hub functi... |
2018 |
| Details |
#4578 Development of a rapid clinical grade assay to detect and monitor sec... |
2018 |
| Details |
#4842 A comparative preclinical study of PARP inhibitors demonstrates super... |
2018 |
| Details |
#5103 Notch is a master regulator of mesenchymal transformation and therape... |
2018 |
| Details |
#5370 Targeted sequencing of actionable mutations to enhance the prog- nost... |
2018 |
| Details |
#5631 Personal neoantigen-targeting vaccination generates neoepitope- speci... |
2018 |
| Details |
#5889 TWIST1 is a key mediator of HGF-MET-driven resistance to tar- geted t... |
2018 |
| Details |
#204 Reconstructing testicular germ cell cancer progression: Primary tu- mo... |
2018 |
| Details |
#462 Hyperactivation of ERK/MAPK pathway reduces pancreatic cancer cells pr... |
2018 |
| Details |
#727 A novel rMVA combination immunotherapy triggers potent innate and adap... |
2018 |
| Details |
#982 Pharmacological DNA-PK inhibition induces ATM/p53 dependent premature ... |
2018 |
| Details |
#1242 Differences of cytochrome P450 1B1 polymorphisms on prostate cancer r... |
2018 |
| Details |
#1509 Cachexia: Leveraging transcriptomics to identify potential thera- peu... |
2018 |
| Details |
#1764 Neurovascular-targeting antibodies discovered using yeast biopan- nin... |
2018 |
| Details |
#2013 microRNAs targeting EMT transcription factors in breast cancer and th... |
2018 |
| Details |
#2275 Individualized drug combination based on single-cell drug pertur- bat... |
2018 |
| Details |
#2532 Wild-type p53 represses MELK expression by blocking the recruit- ment... |
2018 |
| Details |
#2792A Preclinical activity of ADCT-601, a novel pyrrolobenzodiazepine (PBD... |
2018 |
| Details |
#3044 Label-free detection and identifcation of cancer-associated vesicles ... |
2018 |
| Details |
#3302 The molecular landscape of oncogenic signaling pathways in The Cancer... |
2018 |
| Details |
CLINICAL RESEARCH: Adoptive Cell Therapy 3 #3563 Impact of the affnity of c... |
2018 |
| Details |
#3810 Ovarian tumor-induced changes in macrophage phenotype are as- sociate... |
2018 |
| Details |
#4067 Toll-like receptor 2 defciency enhances KRAS-driven lung cancer.... |
2018 |
| Details |
#4317 Cell-type specifc epigenetic effects of tobacco smoking on the im- mu... |
2018 |
| Details |
#4579 The genetic heterogeneity and the molecular evolution of systemic met... |
2018 |
| Details |
#4843 NMS-P293, a PARP-1 selective inhibitor with no trapping activity and ... |
2018 |
| Details |
#5104 Prolactin-induced mammary tumors: A preclinical model of lumi- nal B ... |
2018 |
| Details |
#5371 The Metastatic Breast Cancer Project: Partnering with patients to acc... |
2018 |
| Details |
#5632 Targeted immunotherapy with SV-BR-1-GM: Mechanism of action and compa... |
2018 |
| Details |
#5890 Aurora-A potentiates chemoresistance via regulating the microRNA biog... |
2018 |
| Details |
#205 Reliance upon ancestral mutations is maintained in colorectal can- cer... |
2018 |
| Details |
#463 Glucose-regulated protein 94 modulates the response of osteosar- coma ... |
2018 |
| Details |
#728 Optimization of peptide vaccines to induce robust antitumor CD4 T-cell... |
2018 |
| Details |
#983 Metabolic radiosensitization: Overcoming the radioresistance of hy- po... |
2018 |
| Details |
#1243 Elucidating the molecular pathogenesis of familial glioma.... |
2018 |
| Details |
#1511 Differential expression analysis and biomarker identifcation in fve s... |
2018 |
| Details |
#1765 A humanized anti-CD47 monoclonal antibody that directly kills human t... |
2018 |
| Details |
#2014 CAMSAP3, a tubulin minus-end binding protein, attenuates epi- thelial... |
2018 |
| Details |
#2276 Effcient curation and ontology mapping of clinical and phenotypic dat... |
2018 |
| Details |
#2533 Regulation of proliferation and metastasis gene expression by DAX-1 (... |
2018 |
| Details |
EXPERIMENTAL AND MOLECULAR THERAPEUTICS: Design, Structure/Activity, and Mo... |
2018 |
| Details |
TUMOR BIOLOGY: Cancer Imaging: Immunology and Systems Analysis in Vivo... |
2018 |
| Details |
#3303 A comprehensive TCGA Pan-Cancer molecular study of gyneco- logic and ... |
2018 |
| Details |
#3564 A combination of chimeric switch-receptor T cells targeting both PD1 ... |
2018 |
| Details |
IMMUNOLOGY: Therapeutic Antibodies, Including Engineered Antibodies 3 #3811... |
2018 |
| Details |
TUMOR BIOLOGY: Determining How the Immune System Drives Tumor Progression... |
2018 |
| Details |
#4318 Identifying drivers of SMARCA4/BRG1-defcient SCCOHT tu- morigenesis b... |
2018 |
| Details |
#4580 Changes in the effcacy of anti-EGFR antibody drugs by exosomes derive... |
2018 |
| Details |
#4844 Evidence of PARP-1 dependent cytotoxic agents with low target affnity... |
2018 |
| Details |
#5106 CRISPR/Cas9-based development of RNAi rat models for drug dis- covery... |
2018 |
| Details |
#5372 Themutationallandscapeofprimarycutaneousmelanoma.... |
2018 |
| Details |
#5633 Development of glycoconjugate-based anticancer vaccines.... |
2018 |
| Details |
#5891 ABCG2 expression contributes to CC-115 resistance.... |
2018 |
| Details |
#206 The Consensus Molecular Classifcation (CMS) of primary colorec- taltum... |
2018 |
| Details |
#464 Cell death and senescence: Role of protein kinase C in promoting senes... |
2018 |
| Details |
#730 Neoantigen identifcation using the ATLAS T cell profling platform high... |
2018 |
| Details |
#984 Systematic annotation of genetic variants that determine sensitivity t... |
2018 |
| Details |
#1244 BHD-associated kidney cancer exhibits unique molecular charac- terist... |
2018 |
| Details |
#1512 Regulation of the CDC42 signaling pathway by IKZF1 in T-cell acute ly... |
2018 |
| Details |
breast cancer stem cells and inhibits TNBC tumor growth.... |
2018 |
| Details |
#2015 Exosomes secreted by highly migratory premalignant lung epithe- lial ... |
2018 |
| Details |
#2277 Machine learning to identify prostate cancer mutations for screen- in... |
2018 |
| Details |
#2534 Single-cell RNA sequencing reveals lung cancer-associated altera- tio... |
2018 |
| Details |
#2794 A novel bis-aspirinyl selenazolidine compound AS-10 as potential colo... |
2018 |
| Details |
#3046 Evaluation of pancreatic ductal adenocarcinoma with acidoCEST MRI.... |
2018 |
| Details |
MOLECULAR AND CELLULAR BIOLOGY / GENETICS: Epigenetic Changes as Molecular ... |
2018 |
| Details |
#3565 T cell receptor signaling-responsive single chain IL-12 and IL-15 sup... |
2018 |
| Details |
#3812 A best in class anti-CD38 antibody with antitumor and immune- modulat... |
2018 |
| Details |
#4068 Galectin-1 intensifes immunosuppression in head and neck cancer by bo... |
2018 |
| Details |
#4319 Epigenetic reprogramming associated with BRCA1 loss of function in ov... |
2018 |
| Details |
#4581 Feasibility of an amplicon-based liquid biopsy for ALK and ROS1 fu... |
2018 |
| Details |
#4845 Preclinical evaluation of HWH340, a novel PARP inhibitor.... |
2018 |
| Details |
#5107 A novel MTA1 knock-in mouse model for the mechanistic and ther- apeut... |
2018 |
| Details |
#5373 The Oxford Ovarian Cancer Predict Chemotherapy Response (OXO-PCR) stu... |
2018 |
| Details |
#5634 Eradication of breast carcinoma with bone metastasis by autolo- gous ... |
2018 |
| Details |
#5892 miR-217 sensitizes chronic myelogenous leukemia cells to tyrosine kin... |
2018 |
| Details |
#207 CML as a prototypical malignancy.... |
2018 |
| Details |
#465 Regulation of HMGB1 release protects chemoradiotherapy-associ- ated mu... |
2018 |
| Details |
#731 A minigene platform to validate novel immunogenic peptides aris- ing f... |
2018 |
| Details |
TUMOR BIOLOGY: Patient-Derived Models of Cancer: Present and Future #985 Th... |
2018 |
| Details |
#1245 Identifcation of germline variants in cancer susceptibility genes in ... |
2018 |
| Details |
#1513 Epigenetic regulation of CD117 expression in B-cell acute lympho- bla... |
2018 |
| Details |
#1767 Synergy between intratumoral immunotoxin and systemic anti- CTLA-4 pr... |
2018 |
| Details |
#2016 Potential role of polo-like kinase 1 in epithelial-mesenchymal tran- ... |
2018 |
| Details |
#2278 Scalability and reliability improvements to the Iso-Seq analysis pipe... |
2018 |
| Details |
#2535 Single-cell transcriptome analysis on lymphocytes of GATA2 def- cienc... |
2018 |
| Details |
#2795 Screening and characterization of drugs that inhibit the ubiquitin- p... |
2018 |
| Details |
#3047 Development and initial application of a porcine-specifc MRI and MRE ... |
2018 |
| Details |
#3305 Cell-of-origin differentiation stages defne methylation-based sub- ty... |
2018 |
| Details |
#3566 Enhanced expansion and tumor targeting of adoptively transferred T ce... |
2018 |
| Details |
#3813 Development of JNJ-64164711, a low fucose anti-GITR antibody for enha... |
2018 |
| Details |
#4069 Evaluation of inflammatory infltration (tumor infltrating lym- phocyt... |
2018 |
| Details |
#4320 p53 binding sites in normal and cancer cells are characterized by dis... |
2018 |
| Details |
#4582 Capturing T cell receptor clones from circulating free DNA in can- ce... |
2018 |
| Details |
#4846 Targeting BRCA1 -mutated cancer cells with elesclomol.... |
2018 |
| Details |
#5108 The role of H2afy in normal and malignant hematopoiesis.... |
2018 |
| Details |
#5374 Uterine sarcomas: A preliminary study for characterization of a speci... |
2018 |
| Details |
#5635 The development to peptide vaccine targeting heat shock protein 90 to... |
2018 |
| Details |
#5893 Expression and role of autophagy-associated p62 (SQSTM1) in multidrug... |
2018 |
| Details |
#208 Multi-omics analysis in primary cell cultures reveals the genomic basi... |
2018 |
| Details |
#466 Cellular senescence drives skin carcinogenesis.... |
2018 |
| Details |
-gal epitopes.... |
2018 |
| Details |
#986 The National Cancer Institutes patient-derived models repository (PDMR... |
2018 |
| Details |
#1246 A family history of CRC confers protection against other cancers in a... |
2018 |
| Details |
#1514 Role of polycomb proteins in neuroendocrine prostate cancer.... |
2018 |
| Details |
3 retains full anti- tumor effcacy and generates an improved metabolic prof... |
2018 |
| Details |
#2017 Phenotypic plasticity and class switching in ovarian cancer.... |
2018 |
| Details |
#2279 The GenePattern Notebook environment for reproducible cancer research... |
2018 |
| Details |
#2536 Unique HPRT1 upregulation in malignant tissue: Potential use as diagn... |
2018 |
| Details |
#2796 Predicting in vivo effcacy from in vitro data: Quantitative systems p... |
2018 |
| Details |
#3048 Deep learning to predict survival prognosis for patients with non- sm... |
2018 |
| Details |
#3306 The clinical importance of DNA methylation signatures in chronic lymp... |
2018 |
| Details |
#3567 Novel approaches to high-affnity TCR isolation for clinical trans- la... |
2018 |
| Details |
#3814 TriTACs are novel T cell-engaging therapeutic proteins optimized for ... |
2018 |
| Details |
B path- way, components of the tumor microenvironment and cancer-specifc su... |
2018 |
| Details |
#4321 Up-regulation of METTL3 promoted m6A modifcation and epige- netic sil... |
2018 |
| Details |
#4583 Combined analysis of circulating tumor cells, fecal occult blood test... |
2018 |
| Details |
#4847 Evaluation of the combination of olaparib and cediranib in small- cel... |
2018 |
| Details |
#5109 Somatic CRISPR/Cas9-mediated gene editing enables versatile brain tum... |
2018 |
| Details |
#5375 Whole-genome sequencing reveals genomic signatures associated with th... |
2018 |
| Details |
#5637 Combination of oncolytic vaccinia virus and immune checkpoint blockad... |
2018 |
| Details |
#5894 Snail reduces the antitumor effcacy of mTOR kinase inhibitors by tran... |
2018 |
| Details |
#209 Laser capture microdissection of metastatic colon adenocarcinoma sampl... |
2018 |
| Details |
#468 Antioxidant supplements may accelerate the formation and progres- sion... |
2018 |
| Details |
#733 Modulating T cell immunity in tumors by targeting PD-L1 and neo- antig... |
2018 |
| Details |
#987 Organoid-based characterization of patient tumors and microenvi- ronme... |
2018 |
| Details |
#1247 Hereditary paraganglioma-pheochromocytoma syndrome: Pat- terns of pre... |
2018 |
| Details |
#1515 NCOA3 promotes tumor growth by activating telomerase reverse transcri... |
2018 |
| Details |
#1769 Antibody blockade of IL1RAP signaling reduces metastasis in a breast ... |
2018 |
| Details |
inhibits urothelial cell invasion by attenuating epithelial-to-mesenchymal... |
2018 |
| Details |
#2280 Systematic analysis of causal noncoding mutations in pediatric B- cel... |
2018 |
| Details |
#2537 Regulation of LMO2 oncogene expression in high-risk B-cell acute lymp... |
2018 |
| Details |
#2797 Synthesis and evaluation of derivatives of selective inhibitor ERGi U... |
2018 |
| Details |
#3049 Dexamethasone pretreatment impairs the TS inhibition-mediated flare i... |
2018 |
| Details |
#3307 BRCA1 promoter methylation analyzed in 1032 primary breast cancers pr... |
2018 |
| Details |
#3568 Phosphatidylserinetargetingantibodyenhancesantitumor activity of CAR ... |
2018 |
| Details |
#3815 Decomposition of parameters contributing to the improved thera- peuti... |
2018 |
| Details |
#4071 Investigation of thyroid tumor microenvironment by immunohis- tochemi... |
2018 |
| Details |
#4322 Atrx inactivation drives motility and dysregulates differentiation in... |
2018 |
| Details |
#4584 High-defnition single-cell analysis of liquid and solid biopsies re- ... |
2018 |
| Details |
#4848 Preclinical antitumor activity of novel DNA polymerase 1 (POLA1 ) in... |
2018 |
| Details |
#5110 Runx knockout in breast luminal stem/progenitor cells induced precanc... |
2018 |
| Details |
#5376 Whole-exome sequencing of acquired nevi identifes novel mecha- nisms ... |
2018 |
| Details |
#5638 A tetanus-way of improving synthetic long peptide tumor vaccina- tion... |
2018 |
| Details |
#5895 Targeting RhoA-regulated gene transcription in drug-resistant melanom... |
2018 |
| Details |
#210 Uncovering a novel layer of complexity in the architecture of pancre- ... |
2018 |
| Details |
#469 Therapy-induced senescence associated secretory phenotype en- hances b... |
2018 |
| Details |
EXPERIMENTAL AND MOLECULAR THERAPEUTICS: Antibody-Drug Conjugates: Agents a... |
2018 |
| Details |
#988 Short-term culture of organotypic tumor spheroids derived from patient... |
2018 |
| Details |
PREVENTION RESEARCH: Molecular Mechanisms and Targets for Cancer Prevention... |
2018 |
| Details |
#1516 BAT-1up-regulationdecreasescellinvasionandmigrationinvitro.... |
2018 |
| Details |
#1770 Morab-202, a folate receptor alpha-targeted antibody-drug conju- gate... |
2018 |
| Details |
#2019 Extracellular ATP induces EMT and metastatic activities in non- small... |
2018 |
| Details |
#2281 Flexible discovery of recurrent coding and non-coding mutations in tu... |
2018 |
| Details |
in the invasion regulation of ovarian epithelial cell cancer.... |
2018 |
| Details |
#2798 Folate receptor-targeted cancer chemotherapy with novel 6-substi- tut... |
2018 |
| Details |
#3050 Imaging tissue extracellular pH for the differential diagnosis of coc... |
2018 |
| Details |
#3308 Urine epigenetic biomarkers for NSCLC diagnosis.... |
2018 |
| Details |
#3569 Humanized mouse model of MAGE-A1-targeted anti-melanoma T cell therap... |
2018 |
| Details |
#3816 Effcacy of CDX-1140, an agonist CD40 antibody, in preclinical tumor m... |
2018 |
| Details |
#4072 Direct transdifferentiation of glioblastoma cells to antigen-pre- sen... |
2018 |
| Details |
mouse model.... |
2018 |
| Details |
#4585 Development of multi-marker capture and analysis of circulating tumor... |
2018 |
| Details |
#4849 Targeting the lethal pediatric atypical teratoid/rhabdoid tumors with... |
2018 |
| Details |
#5111 Gene editing in the NSG mouse strain and its genetic derivatives.... |
2018 |
| Details |
#5377 Tracking genomic and epigenomic evolution from preneoplastic lesions ... |
2018 |
| Details |
#5639 Changes in local and peripheral T cell diversity after HPV E7 anti- g... |
2018 |
| Details |
#5896 Downregulation of calcium-sensing receptor enhances MET-medi- ated pr... |
2018 |
| Details |
#211 Spin coated peripheral blood flm reveals tumor heterogeneity in circul... |
2018 |
| Details |
#470 p53 isoform delta133p53 in tumor senescence.... |
2018 |
| Details |
#735 SAR of amanitin and optimization of linker-amanitin derivatives for so... |
2018 |
| Details |
#989 Organoid cultures from normal and cancer-prone human breast tis- sues ... |
2018 |
| Details |
#1249 Animal model in the prevention of alcoholic pancreatitis.... |
2018 |
| Details |
#1517 Retinoic acid-dependent profles of gene expression in sensitive and r... |
2018 |
| Details |
#1771 BAY 1834942 is an immunotherapeutic antibody blocking the novel immun... |
2018 |
| Details |
#2020 SAHA and EGCG affect metastatic potential to varying degrees in three... |
2018 |
| Details |
#2282 VIP:Asystembiologyplatformforcelllinecentricintegrativeanal- ysis of ... |
2018 |
| Details |
#2539 Antiapoptotic gene expression signature reveals a combined talk to pr... |
2018 |
| Details |
#2799 New-generationglucosetransporterinhibitorstargetingnon-small cell lun... |
2018 |
| Details |
#3051 Prognostic value of 18 F-FDG PET/CT parameters in patients with prim... |
2018 |
| Details |
#3309 Circulatingepigeneticbiomarkersfortheearlydetectionofovarian cancer.... |
2018 |
| Details |
#3570 Adoptive transfer of tumor antigen-specifc CTLs requires anti- CTLA-4... |
2018 |
| Details |
#3817 Improved T cell activation bioassays to facilitate the development of... |
2018 |
| Details |
TUMOR BIOLOGY: Mechanisms and Models of Gastrointestinal Malignancies #4073... |
2018 |
| Details |
#4324 Systematic characterization of A-to-I RNA editing in cancer devel- op... |
2018 |
| Details |
#4586 Evaluation of available blood collection tubes for use in stabilizing... |
2018 |
| Details |
#4850 The minor groove binding agent quinacrine inhibits growth and increas... |
2018 |
| Details |
#5112 U2af1 , a spliceosome gene commonly mutated in MDS, is required for h... |
2018 |
| Details |
#5378 Whole exome and RNA sequencing identify novel somatic muta- tions in ... |
2018 |
| Details |
#5640 Developmentofapersonalizedpancreaticcancervaccine.... |
2018 |
| Details |
#5897 Role of polymerase II associated factor 1, PAF1, in docetaxel resis- ... |
2018 |
| Details |
#212 High-resolution barcoding in patient-derived xenografts of triple- neg... |
2018 |
| Details |
MOLECULAR AND CELLULAR BIOLOGY / GENETICS: MicroRNA Regulation in Cancer Bi... |
2018 |
| Details |
#736 Pyridinobenzodiazepines (PDDs): A new class of sequence-selective DNA ... |
2018 |
| Details |
#990 Single-cell profling of small cell lung cancer circulating tumor cell-... |
2018 |
| Details |
EPIDEMIOLOGY: Genetic Contributions to Cancer Epidemiology 2: Next-Generati... |
2018 |
| Details |
#1518 Gene expression of trefoil proteins, gastrokines and mucins in In- di... |
2018 |
| Details |
#1772 Immunotherapy of colorectal cancer by the T-cell targeted DART protei... |
2018 |
| Details |
#2021 The CXCL12/CXCR4 axis drives epithelial-mesenchymal transi- tion in r... |
2018 |
| Details |
#2283 PCR-based validation of novel cancer-predisposing mutations identifed... |
2018 |
| Details |
#2540 TRIM24 is an oncogenic transcriptional co-activator of STAT3 in gliob... |
2018 |
| Details |
EXPERIMENTAL AND MOLECULAR THERAPEUTICS: Design, Structure/Activity, and Mo... |
2018 |
| Details |
TUMOR BIOLOGY: Cancer Stem Cell Characterization #3052 Identifcation and ch... |
2018 |
| Details |
#3310 Non-invasive diagnosis of colorectal cancer via targeted high- throug... |
2018 |
| Details |
#3571 Use of a universal CAR T cell plus bispecifc adapters to eradicate an... |
2018 |
| Details |
T cells through concomitant engagement of a T cell costimulatory receptor.... |
2018 |
| Details |
#4074 Pten haploinsuffciency promotes tumor invasion and carcinogen- esis ... |
2018 |
| Details |
#4325 Cisplatin treatment of testicular cancer introduces long-term changes... |
2018 |
| Details |
#4587 ESR1 methylation in primary tumors and paired circulating tumor DNA ... |
2018 |
| Details |
#4851 Potent cell cycle inhibitors suitable for treatment of multidrug- res... |
2018 |
| Details |
#5113 Spontaneous tumors in aging colonies of C57BL/6J mice.... |
2018 |
| Details |
#5379 Stratifcation of colorectal cancer patients based on various se- quen... |
2018 |
| Details |
#5641 Synergy of immunomodulators delivered by an HSV-1 oncolytic virus can... |
2018 |
| Details |
#5898 Asystemsapproachfordeterminingthemechanismofresistanceto tumor treati... |
2018 |
| Details |
#213 Exome sequencing of paired primary and relapsed small cell lung cancer... |
2018 |
| Details |
#472 Tumor DNA methylation and microRNA expression in breast can- cer among... |
2018 |
| Details |
#737 Antibody drug conjugates with anthracycline payload induce tumor- sele... |
2018 |
| Details |
#991 Development and characterization of patient derived xenografts from ce... |
2018 |
| Details |
#1250 Evaluation of the prevention by pioglitazone/metformin of ER- positiv... |
2018 |
| Details |
#1519 TonEBP promotes hepatocellular carcinogenesis, recurrence, and metast... |
2018 |
| Details |
#1773 HPN424, a half-life extended, PSMA/CD3-specifc TriTAC for the treatme... |
2018 |
| Details |
drives melanoma cell epithelial-mes- enchymal transition by activating vim... |
2018 |
| Details |
#2284 Semiautomated MRI segmentation workflow for glioblastoma treated by T... |
2018 |
| Details |
#2541 Combined androgen and glucocorticoid receptor (AR/GR) activity drives... |
2018 |
| Details |
#2801 Novel selenodiazoles as antitumor and radical scavenging agents.... |
2018 |
| Details |
#3053 Characterization of cancer stem cell subpopulations from patient- der... |
2018 |
| Details |
#3311 Loss of EZH2 at tumor invasive front is correlated with higher aggres... |
2018 |
| Details |
#3572 CART-cellstargetingthekappamyelomaantigenforthetreatment of multiple ... |
2018 |
| Details |
#3819 INCAGN02385 is an antagonist antibody targeting the co-inhibi- tory r... |
2018 |
| Details |
#4075 Role of yes-associated protein 1 (YAP1) in human pancreatic ductal ad... |
2018 |
| Details |
#4326 The chromatin context and consequence of cisplatin-adduct DNA damage.... |
2018 |
| Details |
#4588 Prognostic association of plasma cell free DNA (cfDNA) copy num- ber ... |
2018 |
| Details |
#4852 Induction of HRD by targeting G9a and MTDH in DNA repair profcient en... |
2018 |
| Details |
#5115 Establishing tumoroid and mouse models for functional validation of p... |
2018 |
| Details |
#5380 Whole-exome sequencing of Brazilian non-small cell lung cancer.... |
2018 |
| Details |
#5642 Electroporation as a feasible method for antigen delivering into vect... |
2018 |
| Details |
#5899 Genome-wide CRISPR-Cas9 screening identifes genetic vulnera- bilities... |
2018 |
| Details |
#214 Genetic and transcriptional instability alters cell line drug response... |
2018 |
| Details |
#473 miR-135b mediates gemcitabine sensitivity in breast cancer cells by mo... |
2018 |
| Details |
#738 Development of an HPLC method for the assessment of hydropho- bicity o... |
2018 |
| Details |
TUMOR BIOLOGY: Building the Microenvironment through Crosstalk #992 Pancrea... |
2018 |
| Details |
#1251 Fisetin for the management of PIK3CA -mutant colorectal cancer.... |
2018 |
| Details |
#1520 Regulation of stemness by perturbation of OCT4-PP1 axis reduces malig... |
2018 |
| Details |
#1774 External beam radiation therapy and androgen deprivation ther- apy in... |
2018 |
| Details |
#2023 RhebL1 is involved in epithelial mesenchymal transition of breast can... |
2018 |
| Details |
#2285 Regtools: Integrated analysis of genomic and transcriptomic data for ... |
2018 |
| Details |
in human prostate and melanoma cell lines.... |
2018 |
| Details |
#2802 Discovery of the frst selective and cell-active eIF4A3 inhibitors.... |
2018 |
| Details |
#3054 High-throughput microfluidic Labyrinth for the label-free isola- tion... |
2018 |
| Details |
#3312 Identifcationoftissue-of-originincancerofunknownprimarysite (CUPS) us... |
2018 |
| Details |
#3573 Novel DNA vectors encoding a chimeric antigen receptor mediate long t... |
2018 |
| Details |
#3820 Novel PD-1/GITRL bispecifc fusion protein delivering concurrent T cel... |
2018 |
| Details |
#4076 Gut microbiota and metabolite-driven phenotype modulation in a mouse ... |
2018 |
| Details |
#4327 The epigenetic effects of benzo[ a ]pyrene exposure.... |
2018 |
| Details |
#4589 Expression of PD-L1 on circulating breast cancer cells: Correlation w... |
2018 |
| Details |
#4853 Regulation of proteolytic repair of Top2 covalent complexes.... |
2018 |
| Details |
#5116 Development of murine tumor homograft panels and their genetic fngerp... |
2018 |
| Details |
#5381 Understanding the genesis and oncogenic consequences of tandem duplic... |
2018 |
| Details |
repertoire analysis from a prophylactic MUC1 cancer vac- cine trial.... |
2018 |
| Details |
#5900 Inhibition of CYP3A5 down-regulates cancer drug resistance genes and ... |
2018 |
| Details |
#215 Reconstructing the Barretts-dysplasia-adenocarcinoma sequence from pat... |
2018 |
| Details |
#474 Alterations of micro-RNAs are associated with melanoma resistance toBR... |
2018 |
| Details |
EXPERIMENTAL AND MOLECULAR THERAPEUTICS: Antibody-Drug Conjugates: Agents a... |
2018 |
| Details |
#993 Wnt-er is coming: WNT5A promotes a slow cycling phenotype via p53 in c... |
2018 |
| Details |
#1252 RNA-Seq transcriptome analyses of human LNCaP prostate cancer cells t... |
2018 |
| Details |
#1521 Role of Trim28 in prostate cancer.... |
2018 |
| Details |
#1775 Development of fully humanized N-cadherin monoclonal antibod- ies for... |
2018 |
| Details |
#2024 Hyaluronic acid conjugated nanoparticle delivery of siTWIST re- duces... |
2018 |
| Details |
#2286 Feature-based clinical interpretation of whole exome and tran- script... |
2018 |
| Details |
CLINICAL RESEARCH: Adoptive Cell Therapy 2 #2543 Concurrent chemotherapy an... |
2018 |
| Details |
#2803 Novel auristatins with high activity on efflux-positive models and de... |
2018 |
| Details |
#3055 AmodelofCSCconvertedfromiPSCintheconditionedmediumof HCC paving the w... |
2018 |
| Details |
#3313 Epigenetic biomarkers of prognosis in stage IIA colon cancer.... |
2018 |
| Details |
#3574 Cytokine-autonomous, CAR-directed, off-the-shelf natural killer cells... |
2018 |
| Details |
#3821 The neoantigen-targeting antibody NEO-201 enhances NK cell- dependent... |
2018 |
| Details |
#4077 A new mouse model of gastric adenocarcinoma: A valuable tool for prec... |
2018 |
| Details |
#4328 hTERT protein expression, hTERT methylation and HPV infection in uter... |
2018 |
| Details |
#4590 Larger family sizes improve stochastic error correction during un- ta... |
2018 |
| Details |
#4854 Targeting ribonucleotide reductase M2 using didox causes inhibi- tion... |
2018 |
| Details |
#5117 A murine hematogenous bone metastatic cancer to model sponta- neous m... |
2018 |
| Details |
#5382 TheevaluationoftheDEPArrayNXT TM asaclinicalapplicationfor somatic tu... |
2018 |
| Details |
#5644 GenerationofclinicalgradeautologousTLR7,8-polarizedfastden- dritic ce... |
2018 |
| Details |
#5901 The role of POU3F2 in the aggressive behavior of neuroendocrine prost... |
2018 |
| Details |
#216 Functional stability, progression and evolution of targeted drug sen- ... |
2018 |
| Details |
#475 Characterization of miR-21 expression in budding colon cancer cells us... |
2018 |
| Details |
#741 Targeting trastuzumab and T-DM-1 resistant breast cancer cells with EV... |
2018 |
| Details |
#994 Cancer cells induce a protumorigenic senescent phenotype in fbro- blas... |
2018 |
| Details |
#1253 Dissecting the signaling cascades involved in growth inhibition and a... |
2018 |
| Details |
MOLECULAR AND CELLULAR BIOLOGY / GENETICS: Targeting the Cell Cycle: Mechan... |
2018 |
| Details |
#1776 High-affnity anti-galectin-3 antibodies targeting oncogenic prop- ert... |
2018 |
| Details |
#2025 CD147/EMMPRIN mediates epithelial-mesenchymal transition of head and ... |
2018 |
| Details |
#2287 Precise common and rare germline CNV calling with GATK.... |
2018 |
| Details |
#2544 Anti-MUC1* CAR T for solid tumors.... |
2018 |
| Details |
#2804 Identifying an optimal site for linker conjugation of the taccalono- ... |
2018 |
| Details |
#3056 Lung tumor spheres as in vitro platform for testing new therapeutic s... |
2018 |
| Details |
#3314 Heritable methylation marks associated with prostate and breast cance... |
2018 |
| Details |
CLINICAL RESEARCH: Adoptive Cell Therapy 3... |
2018 |
| Details |
#3822 Characterization of the frst chicken-derived anti-PD-1 clinical stage... |
2018 |
| Details |
#4078 Sleeping Beauty transposon mutagenesis identifes genes involved in co... |
2018 |
| Details |
#4329 Enhancer mapping in triple-negative breast cancer as a tool for novel... |
2018 |
| Details |
#4591 Integration of genomic analysis and assessment of pre-analytic variab... |
2018 |
| Details |
#4855 Indotecan (LMP400), Imidotecan (LMP776) and LMP744: A new class of no... |
2018 |
| Details |
#5118 Development of new alternative in vivo models to study early me- ta... |
2018 |
| Details |
#5383 Tumor evolution of uterine leiomyosarcoma from a benign leiomy- oma p... |
2018 |
| Details |
CANCER CHEMISTRY: Emerging Proteomic Technologies for Cancer Research #5645... |
2018 |
| Details |
#5902 RNA sequencing analysis of taxane-resistant prostate cancer cells rev... |
2018 |
| Details |
#218 The evolutionary history of 2,658 cancers.... |
2018 |
| Details |
#476 A human scFv as a tool to understand the biogenesis of a subset of onc... |
2018 |
| Details |
#742 Nonclinical safety evaluation of STRO-001, a site-specifc anti-CD74 an... |
2018 |
| Details |
-IRAK4 feedforward circuitry drives tumor f- brosis, chemo-resistance and i... |
2018 |
| Details |
#1254 Metformin s potential as a breast cancer preventative agent by al- te... |
2018 |
| Details |
#1523 Repression of IRF4 and CYTIP unleashes anti-tumor interferon response... |
2018 |
| Details |
#1777 REGN4018, a novel MUC16xCD3 bispecifc T-cell engager for the treatmen... |
2018 |
| Details |
#2026 Quantifying the mesenchymal and cancer stem cell properties of C6 gli... |
2018 |
| Details |
#2288 Assessing patient trial readiness for precision cancer medicine clin-... |
2018 |
| Details |
#2545 Antitumor effcacy of Type I polarized dendritic cells in combina- tio... |
2018 |
| Details |
#2805 Combretastatins as highly cytotoxic natural compounds.... |
2018 |
| Details |
#3057 ABCG2-positive cells derived from ABCG2-negative pancreatic cancer ce... |
2018 |
| Details |
liver cancer stem cells by genome-wide DNA methylation analysis.... |
2018 |
| Details |
#3575 Cell therapy with surface-tethered IL-12 improves anti-tumor eff- cac... |
2018 |
| Details |
#3823 Bat4306f, an anti-CD20 antibody devoid of fucose modifcation, demonst... |
2018 |
| Details |
#4079 Perturbations in tat-interacting protein 30 (TIP30) levels contrib- u... |
2018 |
| Details |
#4330 Pan-cancer analysis reveals m 6 A modifcation is functionally im- por... |
2018 |
| Details |
#4592 Verifcation of a complete sample to insight liquid biopsy work- flow:... |
2018 |
| Details |
EXPERIMENTAL AND MOLECULAR THERAPEUTICS: Novel Targets and Inhibitors #4856... |
2018 |
| Details |
#5119 In vivo characterization of the Duffy Antigen Receptor for Chemo- kin... |
2018 |
| Details |
#5384 The Angiosarcoma Project: Generating the genomic landscape of an exce... |
2018 |
| Details |
#5646 Serum functional biomarker discovery with PEP technology.... |
2018 |
| Details |
#5903 The molecular mechanism for producing BQ323636.1 in Tamox- ifen resis... |
2018 |
| Details |
#219 Development of TEAPOT algorithm to reconstruct individual ovar- ian tu... |
2018 |
| Details |
#477 Targeting of ErbB3 with functional cooperative miRNAs enhances effcacy... |
2018 |
| Details |
#743 ABT-806-derived antibody-drug conjugates (ADCs) inhibit growth ofmalig... |
2018 |
| Details |
#996 Host-derived MCP-1 dictates prostate cancer skeletal metastasis in viv... |
2018 |
| Details |
#1255 Delta-tocopherol induced endoplasmic reticulum stress causes au- toph... |
2018 |
| Details |
#1524 A frst-in-class CDK4 inhibitor shows excellent in vitro and in vivo e... |
2018 |
| Details |
#1778 Preclinical characterization of the safety and antitumor activity of ... |
2018 |
| Details |
#2027 P62/IMP2 promotes metastasis in hepatocellular carcinoma (HCC) by reg... |
2018 |
| Details |
#2289 Precision-weighted RNA-seq analyses of molecular abundance (RoMA)ford... |
2018 |
| Details |
#2546 Regulation of CAR-T cell therapy in real time using bispecifc small m... |
2018 |
| Details |
#2806 Inhibition of melanoma development by Isatin analogs.... |
2018 |
| Details |
#3058 Data and resource sharing: Advancing our understanding of glio- blast... |
2018 |
| Details |
#3316 Hypermethylation at the SMPD3 promoter is frequently detected in hepa... |
2018 |
| Details |
#3576 FT500, an off-the-shelf NK cell cancer immunotherapy derived from a m... |
2018 |
| Details |
#3824 Antitumor activity of REGN4659, a fully human anti-CTLA-4 monoclonal ... |
2018 |
| Details |
#4080 An inducible zebrafsh model to dissect the role of beta catenin signa... |
2018 |
| Details |
MOLECULAR AND CELLULAR BIOLOGY / GENETICS: Genomic Profling of Tumors 3 #43... |
2018 |
| Details |
CLINICAL RESEARCH: Liquid Biopsy 4... |
2018 |
| Details |
#4857 Discovery of PF-06855800, a SAM competitive PRMT5 inhibitor with pote... |
2018 |
| Details |
TUMOR BIOLOGY: Metabolism and the Microbiome: Defning the Greater Microenvi... |
2018 |
| Details |
#5385 Supporting neoantigen discovery and monitoring in plasma through anal... |
2018 |
| Details |
#5647 Multivariant analysis to decipher the human pancreatic cancer pro- te... |
2018 |
| Details |
#5904 Post-transcriptional regulation of androgen receptor by DDX3 in prost... |
2018 |
| Details |
#220 Intra-tumor immune heterogeneity is associated with prognosis of oroph... |
2018 |
| Details |
#478 Regulation of MUC13 by microRNA in colorectal cancer.... |
2018 |
| Details |
#744 ADCT-701, a novel pyrrolobenzodiazepine (PBD) dimer-based an- tibody-d... |
2018 |
| Details |
#997 The cholesterol metabolite 27-hydroxycholesterol promotes breast cance... |
2018 |
| Details |
#1256 Lynch syndrome premalignancy upregulates immune checkpoints independe... |
2018 |
| Details |
#1525 SY-1365, a selective CDK7 inhibitor, exhibits potent antitumor activi... |
2018 |
| Details |
#1779 Anti-Mu llerian hormone type II receptor (AMHRII), a cancer tar- get ... |
2018 |
| Details |
#2028 ZEB2 promotes cancer cell survival and angiogenesis by cooperat- ing ... |
2018 |
| Details |
#2290 CellMiner and CellMiner Cross-Database (CDB) as a foundation for the ... |
2018 |
| Details |
#2547 A potential new autologous mast cell cancer immunotherapy.... |
2018 |
| Details |
#2807 Cytotoxic activity of novel organotin compounds against different can... |
2018 |
| Details |
#3059 SOX2 is a novel biomarker for poor long-term outcomes in oral cancer.... |
2018 |
| Details |
#3317 Genes encoding neuropeptide receptors are epigenetic markers in patie... |
2018 |
| Details |
#3577 ApplicationofdeepIL-15backpackstohumanTcellsdemonstrates tunable load... |
2018 |
| Details |
#3825 INCAGN02390, a novel antagonist antibody that targets the co- inhibit... |
2018 |
| Details |
#4081 Podoplanin expression in Kupffer cells and platelet deposition on the... |
2018 |
| Details |
#4332 Meta-analysis of molecular features associated with aggressive prosta... |
2018 |
| Details |
#4593 Genomic profling of cell free DNA (cfDNA) from patients with inflamma... |
2018 |
| Details |
#4858 Effcacy of the protein arginine methyltransferase PRMT5 inhibi- tor G... |
2018 |
| Details |
#5121 Obesity and prostate cancer progression: Role of the chemokine CXCL12... |
2018 |
| Details |
#5386 The Seven Bridges Cancer Genomics Cloud: Enabling reproducible and co... |
2018 |
| Details |
#5648 Proteomics analysis of oral cancer cell-derived extracellular vesi- c... |
2018 |
| Details |
#5905 Sp1 acetylation associates with stemness characteristics in temozolo-... |
2018 |
| Details |
EPIDEMIOLOGY: Genetic Contributions to Cancer Epidemiology 1: GWAS and Path... |
2018 |
| Details |
#479 miR-372 enhances tumorigenesis and drug resistance in oral carci- nom... |
2018 |
| Details |
#745 Development of a novel ron receptor targeted antibody-drug conju- gate... |
2018 |
| Details |
#998 Radiation-induced immunosuppressive macrophages limit CD8 T- cell medi... |
2018 |
| Details |
cancer prevention.... |
2018 |
| Details |
#1526 WEE1 inhibition suppresses esophageal adenocarcinoma tumor growth bot... |
2018 |
| Details |
#1780 Anetumab ravtansine has single-agent activity in mesothelin-ex- press... |
2018 |
| Details |
#2029 Notch signaling inhibitor increases E-selectin/ligand interactions an... |
2018 |
| Details |
#2291 RBP, a community for reproducible bioinformatics.... |
2018 |
| Details |
#2548 An image-based method to detect and quantify T cell mediated cytotoxi... |
2018 |
| Details |
#2808 Simultaneous inhibition of SHP2 phosphatase at two allosteric sites.... |
2018 |
| Details |
#3060 EGFR-mediated interleukin enhancer-binding factor 3 contributes to fo... |
2018 |
| Details |
#3318 Frequent promoter hypermethylation correlates with better prog- nosis... |
2018 |
| Details |
#3578 Unmasking T-cell heterogeneity via single cell transcriptomic pro- fl... |
2018 |
| Details |
#3826 GITRL-Fc biomarker and mechanism study: GITRL-Fc reduces Treg frequen... |
2018 |
| Details |
#4082 Contrasting role for claudin-2 in colitis-associated cancer (CAC) and... |
2018 |
| Details |
#4333 High incidence of ERBB2 amplifcation associated with microsat- elli... |
2018 |
| Details |
#4594 Detection of colorectal cancer related gene mutations from CTC and ct... |
2018 |
| Details |
#4859 JNJ-64619178, a selective and pseudo-irreversible PRMT5 inhibi- tor w... |
2018 |
| Details |
#5122 Obesity promotes tumor growth, reduces breast tumor latency and corre... |
2018 |
| Details |
#5387 Novel targeted single-cell TCR sequencing method used for analy- sis ... |
2018 |
| Details |
#5649 Multi-omics data indicate that primary and lymph node oral cancer cel... |
2018 |
| Details |
#5906 EGFR and SOX2 crosstalk determines EGFR-TKI.... |
2018 |
| Details |
#222 Genome-wide association study of acute lymphoblastic leukemia in child... |
2018 |
| Details |
#480 Regulation of crosstalk between AR and Wnt/Beta-catenin pathways by mi... |
2018 |
| Details |
#746 Development of novel formats of anti-AXL ADCs.... |
2018 |
| Details |
#1000 PD-L1 binding peptide identifed by phage peptide display inhibits PD-... |
2018 |
| Details |
PREVENTION RESEARCH: Molecular Mechanisms and Targets for Cancer Prevention... |
2018 |
| Details |
#1527 Splicing factors determine breast cancer cell mitosis through con- tr... |
2018 |
| Details |
#1781 HPN536, a T cell-engaging, mesothelin/CD3-specifc TriTAC for the trea... |
2018 |
| Details |
-mediated Smad2/3-dependent transcrip- tion of EMT promoting proteins in tr... |
2018 |
| Details |
#2292 ComparisonofQPathandAperioImageAnalysisSystemforquan- tifcation of ER... |
2018 |
| Details |
#2549 Development of CAR T-cell therapy targeting glypican-3 in liver cance... |
2018 |
| Details |
-alkylsulfonamidoa- nilino) quinazoline derivatives as RAF inhibitor.... |
2018 |
| Details |
#3061 The clinicopathologic roles of SOX2 and Oct4 expressions in stage 1 a... |
2018 |
| Details |
#3319 Epigenetic upregulation of E3 ubiquitin ligase CBLC enhances EGFR dys... |
2018 |
| Details |
#3580 Enhancing adoptive cell therapies through exogenous regulation.... |
2018 |
| Details |
#3827 Bispecifc antibodies with an anti-PD-1 backbone for cancer ther- apy ... |
2018 |
| Details |
#4083 Intrahepatic cholangiocarcinoma and gallbladder carcinoma mouse model... |
2018 |
| Details |
#4334 Linked read whole genome sequencing reveals pervasive chromo- somal l... |
2018 |
| Details |
#4595 The VAR2CSA malaria protein effciently retrieves CTCs from a broad sp... |
2018 |
| Details |
#4860 A novel class of small-molecule inhibitors of galectin-1 for prostate... |
2018 |
| Details |
#5123 Changesoforalmicrobiomeproflesassociatedwithoralsquamous cell carcino... |
2018 |
| Details |
#5388 RNA in situ detection and characterization of ALK rearrangement in NS... |
2018 |
| Details |
#5650 Functional proteomics for precise cancer diagnosis and therapy using ... |
2018 |
| Details |
#5907 Fulvestrant resistance in estrogen receptor positive breast cancer mo... |
2018 |
| Details |
TUMOR BIOLOGY: Tumor Heterogeneity 1... |
2018 |
| Details |
#481 QKI, a direct target of miRNA-200, inhibits epithelial-to-mesenchy- ma... |
2018 |
| Details |
#747 A new class of DNA alkylating indolino-benzodiazepine agents (BIAs) li... |
2018 |
| Details |
#1001 Gut microbiota modulate T cell traffcking into human colorectal cance... |
2018 |
| Details |
#1258 MMP23B expression and protein levels in blood and urine are as- socia... |
2018 |
| Details |
CLINICAL RESEARCH: Adoptive Cell Therapy 1 #1530 A multifunctional role for... |
2018 |
| Details |
#1782 Discovery and activity of STRO-002, a novel ADC targeting folate rece... |
2018 |
| Details |
in ovarian carcinoma.... |
2018 |
| Details |
#2293 Outstanding chromosomal expression patterning in human can- cers.... |
2018 |
| Details |
#2550 Generation of CAR-iPS-T cells expressing CD8... |
2018 |
| Details |
#2810 Computationally predicted sensitivity of clinical cohorts identifes d... |
2018 |
| Details |
#3062 Ablation of parathyroid hormone-related protein in the triple neg- at... |
2018 |
| Details |
#3320 Discovery and development of DNA methylation biomarkers in human papi... |
2018 |
| Details |
#3581 Convergence of the specifcity and cross-reactivity of multiple T cell... |
2018 |
| Details |
#3828 Pritumumab mAb binds cell surface expressed vimentin on pancre- atic ... |
2018 |
| Details |
#4084 Identifying characteristics of orthotopic HCC mouse models to predict... |
2018 |
| Details |
#4335 High incidence of POLE and POLD1 mutations in Chinese colorec- ta... |
2018 |
| Details |
#4596 Early noninvasive prediction of response to targeted therapy in non-s... |
2018 |
| Details |
#4861 Initial preclinical evaluation of a novel inhibitor of mitochondrial ... |
2018 |
| Details |
#5125 The relationship between microbiome Fusobacterium nucleatum and auto... |
2018 |
| Details |
MOLECULAR AND CELLULAR BIOLOGY / GENETICS: MicroRNAs as Biomarkers #5389 Ci... |
2018 |
| Details |
#5651 Achieving simultaneous improvements in workflow and multiplex- ing in... |
2018 |
| Details |
#5908 Resistance mechanisms to TP53-MDM2 inhibition identifed by in vivo pi... |
2018 |
| Details |
#223 A meta-analysis of genome-wide association studies of multiple myeloma... |
2018 |
| Details |
#482 Epstein-Barr virus-encoded miRNAs target ATM-mediated re- sponse in na... |
2018 |
| Details |
#748 Non-internalizing site-specifc antibody-drug conjugates based on mayta... |
2018 |
| Details |
T cells derived from oropha- ryngeal tumors is related to the expression o... |
2018 |
| Details |
#1259 Loss of TFF1 promotes growth and chemotherapeutic resistance in gastr... |
2018 |
| Details |
#1531 A bispecifc chimeric-antigen receptor T-cell factory for triple-neg- ... |
2018 |
| Details |
#1783 UMG1, a novel humanized monoclonal antibody against a glysosy- lated-... |
2018 |
| Details |
#2032 CXCR7 promotes the migration and invasion of head and neck squamous c... |
2018 |
| Details |
#2294 Customizable weighted DNA copy-number networks inform onco- genic pat... |
2018 |
| Details |
#2551 Allogeneic CRISPR engineered anti CD70 CAR T cells demonstrate potent... |
2018 |
| Details |
EXPERIMENTAL AND MOLECULAR THERAPEUTICS: Modulation of DNA Damage and Repai... |
2018 |
| Details |
#3063 Stem cell lineage hierarchy by keratin profling in normal human prost... |
2018 |
| Details |
#3321 Dysregulation of m6A RNA methylation regulators in colorectal cancer:... |
2018 |
| Details |
#3582 Inclusion of a Dap10 costimulatory domain enhances anti-tumor effcacy... |
2018 |
| Details |
subunit of MUC4.... |
2018 |
| Details |
#4085 Development of porcine hepatocellular carcinoma cell lines: Com- preh... |
2018 |
| Details |
#4336 Integrative genomic and transcriptomic analysis of leiomyosar- coma.... |
2018 |
| Details |
#4597 The Blood Profling Atlas in Cancer: Accelerating progress through col... |
2018 |
| Details |
#4862 Protein arginine methyltransferase 5 as a tumor promoter and therapeu... |
2018 |
| Details |
#5126 Modulation of lactate in the tumor microenvironment with lactate tran... |
2018 |
| Details |
MOLECULAR AND CELLULAR BIOLOGY / GENETICS: Genomic Profling of Tumors 5... |
2018 |
| Details |
#5652 Validation of novel InSituPlex TM technology utilizing standard chro... |
2018 |
| Details |
EXPERIMENTAL AND MOLECULAR THERAPEUTICS: Therapeutic Approaches Based on Ge... |
2018 |
| Details |
#224 Evidence for a shared genetic basis between breast cancer and mam- mog... |
2018 |
| Details |
#483 BRCA1 protein expression is downregulated by miR-185, miR-93 and miR-1... |
2018 |
| Details |
#749 Antibody internalization assays for cancer drug discovery.... |
2018 |
| Details |
#1003 Improving the functional taxonomy of breast cancer-associated f- brob... |
2018 |
| Details |
#1260 Mechanism of skin cancer chemoprevention by dietary grape: A global p... |
2018 |
| Details |
#1532 Canine CAR T cells therapy for mammary carcinomas in dogs.... |
2018 |
| Details |
#1784 IL-7R targeting therapy for immunoregulation and overcoming steroid r... |
2018 |
| Details |
#2033 Transforming growth factor-b-induced epithelial-mesenchymal transitio... |
2018 |
| Details |
#2295 LinkedOmics: Analyzing multi-omics data within and across 32 cancer t... |
2018 |
| Details |
#2552 Preclinical development of T-cell receptor therapy targeting the 5T4 ... |
2018 |
| Details |
#2812 Status of TGFbeta signaling determines PARP inhibitor sensitivity in ... |
2018 |
| Details |
#3065 Role of noncoding RNA miR 146 alpha and let 7c in epithelial mes- enc... |
2018 |
| Details |
#3322 DNA hypermethylation plays an important role in the epithelial- mesen... |
2018 |
| Details |
#3583 NKG2D as a chimeric antigen receptor - DAP 10 provides optimal co sti... |
2018 |
| Details |
#3830 Monoclonal and bispecifc antibodies against human insulin-like growth... |
2018 |
| Details |
TUMOR BIOLOGY: Mechanisms and Models of Gastrointestinal Malignancies... |
2018 |
| Details |
#4337 Identifcation of novel fusion gene, PUM1-TRAF3, as potent bio- marker... |
2018 |
| Details |
#4598 A comprehensive assessment of the impact of preanalytical vari- ables... |
2018 |
| Details |
#4863 Targeting the NFAT1-MDM2-MDMX network for prostate cancer therapy.... |
2018 |
| Details |
#5127 Eradication of the gut microbiota reduces cancer burden in multi- ple... |
2018 |
| Details |
#5390 microRNA signature of T cell exhaustion.... |
2018 |
| Details |
#5654 Fully automated tissue classifcation by imaging mass spectrome- try, ... |
2018 |
| Details |
EXPERIMENTAL AND MOLECULAR THERAPEUTICS: Regulation of Gene Expression in D... |
2018 |
| Details |
#225 Tumor-infltrating CD8-positive T-lymphocytes in tubo-ovarian high-grad... |
2018 |
| Details |
-catenin signaling pathways.... |
2018 |
| Details |
#750 Modular coiled-coil masking domains for tumor-specifc antibody activat... |
2018 |
| Details |
#1004 Tuft cell chemosensory signaling during pancreatic ductal adeno- carc... |
2018 |
| Details |
#1261 Detection of autophagy in gastric mucosae of Chilean individuals resi... |
2018 |
| Details |
T cells reprogram tumor metabolism and drive oxidative stress-induced tumo... |
2018 |
| Details |
#1785 Pre-clinical development of a novel CD3-CD123 bispecifc T-cell engage... |
2018 |
| Details |
1-induced epithelial-mesenchymal transition in lung can- cer.... |
2018 |
| Details |
#2296 STAR-SEQR: Accurate fusion detection and support for fusion neoantige... |
2018 |
| Details |
CLINICAL RESEARCH: Adoptive Cell Therapy 2... |
2018 |
| Details |
#2813 Effcacy and pharmacokinetics of niraparib in BRCA -mutant and wild-t... |
2018 |
| Details |
#3067 The novel function of keratin 14 (KRT14) in regulating cancer stem ce... |
2018 |
| Details |
#3323 Role of RNA methyltransferase METTL3 in melanoma.... |
2018 |
| Details |
#3584 Characterization of a novel class of engineered (TCR) fusion con- str... |
2018 |
| Details |
#3831 Development of near-infrared photoimmunotherapy targeting GD2-positiv... |
2018 |
| Details |
#4086 Effcient primary culture model of patient-derived epithelial cells fr... |
2018 |
| Details |
#4338 Introduction of CALR mutations to a human erythroleukemia cell line, ... |
2018 |
| Details |
#4599 Detecting MSI phenotype in circulating blood DNA.... |
2018 |
| Details |
#4864 Small-molecule MDM2 antagonists attenuate the senescence-asso- ciated... |
2018 |
| Details |
#5128 Understanding the association of gut microbiota and tumor mi- croenvi... |
2018 |
| Details |
#5391 Evaluation of seq-based biofluid miRNA profling platforms.... |
2018 |
| Details |
#5655 Biophysics in the cellCETSA to study drug binding and cellular proces... |
2018 |
| Details |
#5910 Oncolytic gene editing therapy for the treatment of pediatric rhab- d... |
2018 |
| Details |
#226 Single variant and gene-based replication analysis of reproductive agi... |
2018 |
| Details |
#485 Modulation of microRNA expression in EGFR-tyrosine kinase in- hibitor-... |
2018 |
| Details |
#751 A controlled affnity-guided ADC-linker (MAGNET) technology.... |
2018 |
| Details |
#1005 Combination T cell receptor immunosequencing and multiplex immunohist... |
2018 |
| Details |
#1262 Type-2 cGMP-dependent protein kinase has a tumor-suppressive role in ... |
2018 |
| Details |
#1534 Analysis of CAR 41-BB versus CD28 co-stimulatory domains ex- poses em... |
2018 |
| Details |
#1786 APVO436, a bispecifc anti-CD123 x anti-CD3 ADAPTIR TM mol- ecule for... |
2018 |
| Details |
-activated ATF4 inhibits triple negative breast cancer metastases independe... |
2018 |
| Details |
#2297 Differential analysis of gene expression across the human genome usin... |
2018 |
| Details |
T cells derived from met- astaticcastrationresistantprostatecancer(mCRPC)p... |
2018 |
| Details |
#2814 Antitumor effects of WEE1 inhibitor, AZD1775 alone or in combi- natio... |
2018 |
| Details |
#3068 Chronic alcohol exposure induces malignant transformation of pancreat... |
2018 |
| Details |
#3324 Diagnosis and prognosis of hepatocellular carcinoma with ctDNA methyl... |
2018 |
| Details |
#3585 T cell receptor-stabilized regenerated CD8ab cytotoxic T lympho- cyte... |
2018 |
| Details |
#3832 A proliferation-inducing ligand (APRIL) directly impacts immune regul... |
2018 |
| Details |
#4087 Investigating the novel role of Hippo signaling in mouse pancreas.... |
2018 |
| Details |
#4339 Molecular subtypes and novel genetic mechanisms of primary and acquir... |
2018 |
| Details |
CLINICAL RESEARCH: Liquid Biopsy 4... |
2018 |
| Details |
#4865 BI 907828: A highly potent MDM2 inhibitor with low human dose estimat... |
2018 |
| Details |
#5129 Fusobacterium and co-occurring microbes in primary and meta- static ... |
2018 |
| Details |
#5392 Exosomal miRNA expression profling in triple-negative breast cancer.... |
2018 |
| Details |
#5656 Developing metal-labeled antibody panels for multiplex proteomic char... |
2018 |
| Details |
#5911 A bicistronic adenoviral vector carrying cytosine deaminase and GM-CS... |
2018 |
| Details |
#227 Germline variation at 8q24 and prostate cancer risk in men of European... |
2018 |
| Details |
#486 MicroRNA-30 family members inhibit breast cancer invasion, osteo- mimi... |
2018 |
| Details |
#752 CovisoLinK:NewbacterialtransglutaminaseQ-Tagsubstrateforthe developmen... |
2018 |
| Details |
#1006 Adipsin enhanced clonogenicity and proliferation of human breast canc... |
2018 |
| Details |
#1263 TGF- inhibition as a novel strategy to prevent breast cancer brain me... |
2018 |
| Details |
2 specifc CAR and a PD-L1 specifc switch receptor show increased anti-tumor... |
2018 |
| Details |
IMMUNOLOGY: Therapeutic Antibodies, Including Engineered Antibodies 1... |
2018 |
| Details |
signaling pathways in breast cancer tumors with different subtype is relat... |
2018 |
| Details |
#2298 Understanding tumor biology complexity in the advanced cancer setting... |
2018 |
| Details |
#2554 To clone tumor-specifc TCRs from a cell-based immunotherapy- beneft c... |
2018 |
| Details |
#2815 Ganoderma lucidum chemosensitizes triple negative breast cancer to c... |
2018 |
| Details |
#3070 Cancer stem cells in feld cancerization of oral squamous cell carci- ... |
2018 |
| Details |
#3325 Epigenetics, regulation of cancer immunotherapy response genes, and r... |
2018 |
| Details |
#3586 A universal killer T-cell for adoptive cell therapy of cancer.... |
2018 |
| Details |
#3833 SEA-BCMA: A highly active enhanced antibody for multiple my- eloma.... |
2018 |
| Details |
#4088 Metabolic disease drivers of liver cancer, a new disease paradigm.... |
2018 |
| Details |
#4340 Integrating whole genome and transcriptome analysis to inform treatme... |
2018 |
| Details |
#4600 Biomarker analysis in circulating cell-free DNA in patients treated w... |
2018 |
| Details |
#4866 BI907828:Anovel,potentMDM2inhibitorthatinducesantitumor immunologic m... |
2018 |
| Details |
#5130 Melanoma and breast adenocarcinoma growth inhibition by a 7-ke- tocho... |
2018 |
| Details |
#5393 Exosomal microRNA profles in peritoneal fluids as a therapeutic bioma... |
2018 |
| Details |
#5657 Use of a novel immunofluorescence multiplexing technology, InSi- tuPl... |
2018 |
| Details |
#5912 Sentinel lymph node targeted therapy by oncolytic sendai virus suppre... |
2018 |
| Details |
EPIDEMIOLOGY: Genetic Contributions to Cancer Epidemiology 1: GWAS and Path... |
2018 |
| Details |
#487 MicroRNA regulation of oral squamous cell carcinoma.... |
2018 |
| Details |
#753 Development of an in vivo model system to assess the interplay be- twe... |
2018 |
| Details |
tremelimumab increase T cells and decrease expres- sion of genes involved ... |
2018 |
| Details |
#1264 Commensal microbiota is involved in anti-PD-1 mAb-mediated antitumor ... |
2018 |
| Details |
#1536 Enhancing CAR T cell activity by linking IL-12 expression to the endo... |
2018 |
| Details |
#1787 COVA4231, a potent CD3/CD33 bispecifc FynomAb with IgG-like pharmacok... |
2018 |
| Details |
#2037 E-cadherin enhances immune control of metastatic melanoma.... |
2018 |
| Details |
#2298A Enhanced consideration of context dependence reveals the scope of so... |
2018 |
| Details |
#2555 Engineering adoptive T cell therapy to co-opt Fas ligand-mediated dea... |
2018 |
| Details |
#2816 Patient derived ovarian cancer xenograft (OC-PDX) to study the respon... |
2018 |
| Details |
#3071 The role of Apela in high-grade serous ovarian cancer.... |
2018 |
| Details |
#3326 Upregulation of epigenetic changes acquired by HPV16 E6/E7 on- coprot... |
2018 |
| Details |
#3587 TCR-transduced T cells targeting a truncal mutation caused by a nsSNV... |
2018 |
| Details |
#3834 Antibodies targeting Resokine, a soluble immune modulator, in- hibit ... |
2018 |
| Details |
#4089 Establishment and long-term in vitro culture of organoids derived fro... |
2018 |
| Details |
#4341 Large mutational spectrum of cutaneous melanoma in a Brazilian popula... |
2018 |
| Details |
#4601 Dissecting the spatial heterogeneity of circulating tumor cells re- v... |
2018 |
| Details |
#4867 Treating hepatocellular carcinoma metastasis and overcoming chemoresi... |
2018 |
| Details |
TUMOR BIOLOGY: Metabolism and the Microbiome: Defning the Greater Microenvi... |
2018 |
| Details |
#5394 Initial results from TRANSCAN ERA-NET BREMIR project: Mi- croRNAs exp... |
2018 |
| Details |
#5658 From staining to analysis: End-to-end application of InSituPlexTM tec... |
2018 |
| Details |
#5913 ECO nanoparticle delivery of siRNA targeting DNA repair to en- hance ... |
2018 |
| Details |
#228 Association analysis across different populations identifes 26 new cut... |
2018 |
| Details |
#488 Epigenetic regulation of colorectal cancer stem cells by the miR-221/ ... |
2018 |
| Details |
#754 Unique pharmacologic properties of Dolaflexin-based ADCsa controlled b... |
2018 |
| Details |
#1008 Peroxynitrite mediates the resistance of tumor cells to cytotoxic T c... |
2018 |
| Details |
#1265 Protective effcacy of gut microbiome and microbial metabolites after ... |
2018 |
| Details |
#1537 Anti-CD19 ARTEMIS TM T cells prevent excessive inflammatory cytokine... |
2018 |
| Details |
#1788 Enhanced in vitro/in vivo cytotoxicity against Burkitt lymphoma/ prim... |
2018 |
| Details |
#2038 The role of epithelial-mesenchymal transition in ovarian cancer.... |
2018 |
| Details |
MOLECULAR AND CELLULAR BIOLOGY / GENETICS: CDK and CDK Inhibitors: Mechanis... |
2018 |
| Details |
#2556 Expanded ovarian cancer patient NK cells represent a novel, cyto- tox... |
2018 |
| Details |
EXPERIMENTAL AND MOLECULAR THERAPEUTICS: Modulation of DNA Damage and Repai... |
2018 |
| Details |
#3072 MiRNA-2861 behaves as LCSC biomarker and regulates the HDAC5-ERK sign... |
2018 |
| Details |
#3327 Correlating blood-based DNA methylation markers and prostate cancer r... |
2018 |
| Details |
#3588 ACTallo: A novel approach using gamma-delta T cells to allogeneic cel... |
2018 |
| Details |
EXPERIMENTAL AND MOLECULAR THERAPEUTICS: Novel and Canonical Targets #3835 ... |
2018 |
| Details |
#4090 Generation of a new mouse to model pancreatic cancer-induced cachexia... |
2018 |
| Details |
#4342 Inverted sinonasal papilloma and associated carcinoma-transcrip- tome... |
2018 |
| Details |
#4603 Clinical application and potential usefulness of targeted next-gen- e... |
2018 |
| Details |
#4868 BI 907828: A novel, potent MDM2 inhibitor that is suitable for high-d... |
2018 |
| Details |
#5131 Obese conditions induce changes in stromal fbroblast phenotype.... |
2018 |
| Details |
#5395 MicroRNA-196b-3p identifed from serum microRNA expression profling is... |
2018 |
| Details |
#5659 Multiplex, single-cell proteomic analysis using imaging mass cy- tome... |
2018 |
| Details |
#5914 The porcine model for onocolytic adenovirus-based therapy.... |
2018 |
| Details |
#229 Genome-wide association study by colorectal carcinoma subtype.... |
2018 |
| Details |
-catenin pathway inactivation.... |
2018 |
| Details |
#755 Synthesis and evaluation of sugar alcohol based molecules for drug con... |
2018 |
| Details |
T cells in ovarian cancer progression.... |
2018 |
| Details |
#1267 A novel mitochondria-based targeting to restore therapeutic re- spons... |
2018 |
| Details |
-V(D)J full-length chains of single-cell sequence from human na ve and anti... |
2018 |
| Details |
CD8 T cells, are impaired following brentuximab vedotin treatment in vitro ... |
2018 |
| Details |
#2039 Cordycepin inhibits breast cancer migration and invasion by tar- geti... |
2018 |
| Details |
#2301 Dual targeting of CDK4/6 and MET in metastatic uveal melanoma.... |
2018 |
| Details |
#2557 Assessing the therapeutic effcacy of disease-specifc T-cell biofac- t... |
2018 |
| Details |
#2817 RAD6 promotes acquired chemoresistance and a poor prognostic marker i... |
2018 |
| Details |
#3073 Low copy number of mtDNA is associated with cancer stemness in ESCC.... |
2018 |
| Details |
#3328 Association between LOX expression, LINE-1 DNA methylation and progno... |
2018 |
| Details |
#3589 Preclinical evaluation of mesothelin-specifc T cell receptor (TCR) fu... |
2018 |
| Details |
#3836 Imbalanced nucleotide metabolism sensitizes breast cancer cells to an... |
2018 |
| Details |
#4091 Knockout of genes in the DNA mismatch repair pathway to model colorec... |
2018 |
| Details |
#4343 Molecular identifcation of bladder cancer gene expression sub- types.... |
2018 |
| Details |
#4604 Long noncoding RNA Linc00162, as a novel prognostic marker, modulates... |
2018 |
| Details |
#4869 Discovery and characterization of highly potent and selective USP7 in... |
2018 |
| Details |
#5132 Lactic acidosis-mediated transcriptomic and metabolomic rewir- ing in... |
2018 |
| Details |
#5396 Identifcation of meningioma patients in high risk of tumor recur- ren... |
2018 |
| Details |
#5660 Proteomic comparative assessment of flash-frozen and OCT em- bedded b... |
2018 |
| Details |
#5915 Overexpression of tumor suppressor p53 gene by oncolytic adeno- vir... |
2018 |
| Details |
#230 Joint genome-wide association study of endometrial cancer and ovarian ... |
2018 |
| Details |
#491 Understanding the roles of miRNAs in melanoma susceptibility through m... |
2018 |
| Details |
#756 Development of next-generation antibody-drug conjugates for resis- tan... |
2018 |
| Details |
#1010 Establishing lobular-like and interlobular-like fbroblast cell lines ... |
2018 |
| Details |
#1268 Anti-PD-1 monotherapy outperforms multiple immunotherapy combination ... |
2018 |
| Details |
#1539 In vivo study of natural killer cell cytotoxicity against cholangioca... |
2018 |
| Details |
#1790 TNFR2-targeted elimination of Tregs and tumor-residing T cells in adv... |
2018 |
| Details |
#2040 Withaferin A inhibits epithelial-to-mesenchymal transition in non-sma... |
2018 |
| Details |
#2302 Preclinical evaluation of CDK4/6 inhibitor and biomarker explo- ratio... |
2018 |
| Details |
#2559 Generation and evaluation of an FLT3 CAR-T cell therapy for the treat... |
2018 |
| Details |
#2818 AsiDNA and HDAC inhibitors: A cross-potentiation team working to kill... |
2018 |
| Details |
B activation.... |
2018 |
| Details |
#3329 A newly developed Septin9 gene methylation assay dectecting dou- ble ... |
2018 |
| Details |
#3590 Preclinical evaluation of NKG2D-specifc T cell receptor (TCR) fusionc... |
2018 |
| Details |
#3837 Bumped kinase inhibitor 1553 selectively inhibits androgen recep- tor... |
2018 |
| Details |
#4092 Glycosyltransferase ST6Gal-I promotes pancreatic ductal adeno- carcin... |
2018 |
| Details |
#4344 Low mitochondrial copy number induces resistance to chemother- apy in... |
2018 |
| Details |
#4605 DICER1 mutations are associated with diverse and frequently his- tol... |
2018 |
| Details |
EXPERIMENTAL AND MOLECULAR THERAPEUTICS: Novel Targets and Inhibitors... |
2018 |
| Details |
#5133 Lipids and suppressive functions of MDSC in cancer.... |
2018 |
| Details |
#5397 ExomiRs can distinguish tumor-associated from normal stroma: Potentia... |
2018 |
| Details |
#5661 A multi modal mass spectrometry imaging strategy to profle the metabo... |
2018 |
| Details |
#5916 Engineering an oncolytic adenovirus targeted to the CXCR4 chemokine r... |
2018 |
| Details |
#231 Identifcation of susceptible loci and enriched pathways for post- radi... |
2018 |
| Details |
#492 Downregulation of microRNA-17-5p promotes EMT by targeting vimentin in... |
2018 |
| Details |
#757 Novel warheads for targeted therapies of cancer: The concept and desig... |
2018 |
| Details |
#1011 Tumor cell intrinsic factors dictate T cell infltration and therapeu-... |
2018 |
| Details |
PREVENTION RESEARCH: Molecular Mechanisms and Targets for Cancer Prevention... |
2018 |
| Details |
#1540 Allogeneic chimeric antigen receptor T cells targeting B cell matu- r... |
2018 |
| Details |
#1791 Evolutionary dynamics of non-Hodgkin s lymphoma CAR T cell therapy.... |
2018 |
| Details |
#2041 Suppression of mutant p53-induced EMT by statins have double- edged e... |
2018 |
| Details |
#2303 CDK4/6 inhibition blocks effects of IGFs and insulin in estrogen rece... |
2018 |
| Details |
#2560 Preclinical effcacy of allogeneic anti-CD123 CAR T-cells for the ther... |
2018 |
| Details |
#2819 Targeting histone chaperone FACT complex sensitizes medullo- blastoma... |
2018 |
| Details |
TUMOR BIOLOGY: Carcinogenesis 1 #3075 Type IIB DNA topoisomerase is downreg... |
2018 |
| Details |
#3330 Molecular surgical margin analysis of pancreatic cancers.... |
2018 |
| Details |
CLINICAL RESEARCH: Adoptive Cell Therapy 3... |
2018 |
| Details |
#3838 Inhibition of the spectraplakin protein MACF1 sensitizes glioblas- to... |
2018 |
| Details |
#4093 Preclinical evaluation of novel treatment strategies in patient-de- r... |
2018 |
| Details |
#4345 Molecular comparison of imatinib-na ve and resistant gastrointes- tin... |
2018 |
| Details |
#4606 Subclassifcation of patients with lung adenocarcinoma harboring EGFR ... |
2018 |
| Details |
#4870 TargetedMDM2degradationasanovelandeffcaciouscancerther- apy.... |
2018 |
| Details |
#5134 Desacetylvinblastine monohydrazide disrupts tumor vessels by promotin... |
2018 |
| Details |
#5398 Companion diagnostic for predicting the effcacy of mTOR inhib- itor i... |
2018 |
| Details |
#5662 N-linked glycosylation site mapping in prostate cancer and matched no... |
2018 |
| Details |
#5917 A novel lipid nanoparticle (NBF-006) encapsulating glutathione S-tran... |
2018 |
| Details |
#232 Genome-wide association study (GWAS) of total nicotine equiva- lents: ... |
2018 |
| Details |
#493 Circulating biliary tract microRNA signature discriminates cholan- gio... |
2018 |
| Details |
#758 Head-to-headcomparisonofADCandSMDCproducts,aloneandin combination with... |
2018 |
| Details |
TUMOR BIOLOGY: Adaptation and Checkpoints in Tumorigenesis... |
2018 |
| Details |
#1269 Diosgenin, a naturally occurring steroidal saponin, prevents colon ca... |
2018 |
| Details |
#1541 Directed, unbiased mapping of lentiviral integrations with next gener... |
2018 |
| Details |
B pathway.... |
2018 |
| Details |
/VEGFA axis in breast cancer angiogenesis.... |
2018 |
| Details |
#2304 In vivo E2F reporting reveals effcacious schedules of MEK1/2- CDK4/6 ... |
2018 |
| Details |
CLINICAL RESEARCH: Adoptive Cell Therapy 2... |
2018 |
| Details |
#2820 Synergistic antileukemic activity of the antibody-drug conjugate (IMG... |
2018 |
| Details |
#3076 Smoking behavior weakens the protective effect of mosaic loss of chro... |
2018 |
| Details |
#3331 Development of a sensitive method to detect aberrant DNA meth- ylatio... |
2018 |
| Details |
#3591 CSPG4 as innovative target for CAR redirected CIK lymphocytes against... |
2018 |
| Details |
-catenin-TCF4 interaction sup- presses colorectal cancer growth in vitro an... |
2018 |
| Details |
TUMOR BIOLOGY: Mechanisms and Models of Gastrointestinal Malignancies... |
2018 |
| Details |
#4346 Integrated whole genome profling of the immune tumour interac- tion i... |
2018 |
| Details |
#4607 G1/S transition-related gene mutations associated with survival of he... |
2018 |
| Details |
#4871 Antitumor activity of novel reversible LSD1 inhibitor, HM97211 in pre... |
2018 |
| Details |
#5135 Retrovirus-transduction promotes cell-to-cell transfer of genetic mat... |
2018 |
| Details |
#5399 Correlation of a microRNA expression profle and the prognosis of peni... |
2018 |
| Details |
#5663 Proteomic analysis of exosomes isolated from ccRCC cell lines.... |
2018 |
| Details |
#5918 A novel glutathione S-transferase P (GSTP) siRNA (NDT-05-1040) for th... |
2018 |
| Details |
EPIDEMIOLOGY: Genetic Contributions to Cancer Epidemiology 1: GWAS and Path... |
2018 |
| Details |
#494 Intravital discovery of miRNA drivers of human cancer cell direc- tion... |
2018 |
| Details |
#759 Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in ... |
2018 |
| Details |
#1012 CD20 supports BCR signaling in an intra-clonal aggressive chronic lym... |
2018 |
| Details |
#1270 Potential metabolic and molecular mechanisms of black raspberry- medi... |
2018 |
| Details |
#1542 Safety and effcacy of high purity and activity NK cells therapy in co... |
2018 |
| Details |
#1793 Gastrin-releasing peptide causes transactivation of the EGFR and HER2... |
2018 |
| Details |
#2043 PlGF/VEGFR-1-dependent activation of Dll4/Notch4 pathway contributes ... |
2018 |
| Details |
#2305 Targeting 6-phosphofructo-2-kinase to increase the effcacy of ER and ... |
2018 |
| Details |
#2561 Fully human immunoglobulin heavy chain only-derived CD33 CAR for the ... |
2018 |
| Details |
#2821 Tousled like Kinase 1 binds to and regulates the protein kinase Nek1:... |
2018 |
| Details |
#3077 Kru ppel-like factor 5 and its connection to Sonic Hedgehog signal- i... |
2018 |
| Details |
#3332 Genome-wide DNA methylation profling of peripheral blood leu- kocytes... |
2018 |
| Details |
#3592 Pharmacological intervention to temporally stimulate or inhibit ICAM-... |
2018 |
| Details |
#3840 Plocabulin, a tubulin inhibitor, presents antitumor activity in pa- t... |
2018 |
| Details |
#4095 Active Kras induced metaplasia progression toward gastric neopla- sia... |
2018 |
| Details |
#4347 Integrated single-cell DNA and RNA analysis of intratumoral het- erog... |
2018 |
| Details |
#4608 Immunologic and clinical implications of harboring mutations in misma... |
2018 |
| Details |
#4872 ONC201 induction of apoptosis in hPheo1 cell line supports use of thi... |
2018 |
| Details |
#5136 Development of an RNA hybridization technique for the in situ visual... |
2018 |
| Details |
#5400 A comprehensive analysis of the interactome of miR-21, an estab- lish... |
2018 |
| Details |
#5664 Chemical proteomic platforms to probe metabolic heterogeneity in the ... |
2018 |
| Details |
#5919 Component-specifc qPCR assays for characterization and identity testi... |
2018 |
| Details |
#234 Understanding melanoma susceptibility through GWAS of risk phe- notype... |
2018 |
| Details |
#495 Leptin facilitates ovarian cancer metastasis through miR-28-3p and mat... |
2018 |
| Details |
#760 Conjugation of daratumumab with 225 actinium greatly increases its an... |
2018 |
| Details |
#1013 Analyzing infltrating B cell populations in the tumor microenvi- ronm... |
2018 |
| Details |
#1271 Restricted feeding of a high-fat diet to the dark phase of the day at... |
2018 |
| Details |
#1543 Upregulationofmannose6-phosphatereceptor(MPR)hasapoten- tial to incre... |
2018 |
| Details |
#1794 The FES-related tyrosine kinase associates with and activates the ins... |
2018 |
| Details |
#2044 Lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) modulates... |
2018 |
| Details |
#2306 Transcriptional and post-transcriptional upregulation of p27 me- diat... |
2018 |
| Details |
#2562 Affnity-enhanced T-cell receptor (TCR) for adoptive T-cell ther- apy ... |
2018 |
| Details |
#2822 ATR inhibitors are active as single agents and in combination with PA... |
2018 |
| Details |
#3078 The fer/FerT cell survival pathway of the ancestral sponge ( Sycon ra... |
2018 |
| Details |
#3333 Detection of IDH1 R132H mutation in situ in human astrocytoma and gli... |
2018 |
| Details |
CLINICAL RESEARCH: Biomarker Discovery 4 #3593 Noncoding RNAs in early dete... |
2018 |
| Details |
#3841 Biologic evaluation of heterocyclic pyrimidines as novel tubulin inhi... |
2018 |
| Details |
#4096 Stage-defned, transgenic immunocompetent mouse model (ASV-B) to inves... |
2018 |
| Details |
#4348 In depth molecular analysis of 183 primary DCIS lesions and 78 subseq... |
2018 |
| Details |
#4609 High-grade TP53-mutated endometrial carcinomas have decreased NRF2 an... |
2018 |
| Details |
#4873 Therapeutic targeting of LSD1 in Ewing sarcoma with SP-2509.... |
2018 |
| Details |
#5137 Tryptophan catabolism in ovarian cancer.... |
2018 |
| Details |
#5401 Dysregulated microRNAs in aflatoxin-induced hepatocellular car- cinom... |
2018 |
| Details |
#5666 Octaplex spectral imaging of non-small cell lung cancer (NSCLC): In-d... |
2018 |
| Details |
#5920 Antitumor effcacy of a dual stromal and tumor targeted oncolytic meas... |
2018 |
| Details |
#235 Type 2 diabetes and glycemic traits in relation to colorectal cancer r... |
2018 |
| Details |
#496 The synergistic role of miR-150-5p and miR-661 in regulating epi- thel... |
2018 |
| Details |
-catenin activation for the treatment of hepatocellular carcinoma.... |
2018 |
| Details |
#1014 Pharmacological modulation of PDAC stroma to enhance check- point blo... |
2018 |
| Details |
#1272 Docosahexaenoic acid supplementation enhances the response of PC-3 pr... |
2018 |
| Details |
#1546 Low-molecular-weight protein tyrosine phosphatase is a useful bio- ma... |
2018 |
| Details |
#1795 Darolutamide demonstrates greater in vivo activity than enzalut- amid... |
2018 |
| Details |
#2045 Mechanistic insights into the role of cAMP-regulated EPAC1 in tumor-i... |
2018 |
| Details |
#2307 Differential effects of N-terminal vs C-terminal truncating CDKN1A m... |
2018 |
| Details |
#2563 Macrophage Toll-like receptor-chimeric antigen receptors (MOTO-CARs) ... |
2018 |
| Details |
#2823 DNA methyltransferase inhibitors sensitize NSCLC cells to PARP inhibi... |
2018 |
| Details |
TUMOR BIOLOGY: Cancer Stem Cell Characterization... |
2018 |
| Details |
MOLECULAR AND CELLULAR BIOLOGY / GENETICS: Epigenetic Changes as Molecular ... |
2018 |
| Details |
#3594 DEK overexpression in breast epithelial tissue creates a pro-onco- ge... |
2018 |
| Details |
#3842 Potent antitumor activity of the HSP90 inhibitor SNX-2112 in type 1 p... |
2018 |
| Details |
#4097 Maintenance of primary human colorectal cancer microenviron- ment usi... |
2018 |
| Details |
#4349 Higher level of tumor mutational burden and 11q13 amplifcation in Chi... |
2018 |
| Details |
#4610 Inflammation-associated microsatellite alterations in colorectal canc... |
2018 |
| Details |
EXPERIMENTAL AND MOLECULAR THERAPEUTICS: Novel Targets and Inhibitors... |
2018 |
| Details |
#5138 Comparative profling for bacterial inhabitance in pancreatic duc- tal... |
2018 |
| Details |
#5402 A panel of miRNAs for diagnosis of wild-type thyroid nodules with pre... |
2018 |
| Details |
#5667 High-throughput analysis of MAPK and JAK-STAT signaling in CT26 tumor... |
2018 |
| Details |
#5921 Systemic treatment with mesothelin-targeted oncolytic adenovirus show... |
2018 |
| Details |
#236 Identifcation of novel cancer target genes by combining data from the ... |
2018 |
| Details |
#497 Identifcation of master microRNA regulatory networks for the mes- ench... |
2018 |
| Details |
#763 PLAC1 interacts with FGF7 and promotes phosphorylation of FGFR2 and AK... |
2018 |
| Details |
TUMOR BIOLOGY: Adaptation and Checkpoints in Tumorigenesis... |
2018 |
| Details |
#1273 Effect of a Western diet on colitis-associated colon tumor forma- tio... |
2018 |
| Details |
#1547 Expressionofepithelial-to-mesenchymaltransitionmarkers(EMT)in treated... |
2018 |
| Details |
#1796 Repurposing CRISPR to study aberrant AR signaling in models of castra... |
2018 |
| Details |
#2046 Structural analysis of VEGFR2 function blocking antibodies.... |
2018 |
| Details |
#2308 Salicylic acid metabolites and derivatives inhibit CDK activity: Nove... |
2018 |
| Details |
#2564 Selection of affnity-enhanced T-cell receptors for adoptive T-cell th... |
2018 |
| Details |
#2824 Charting the landscape of genomic instability in acute myeloid leu- k... |
2018 |
| Details |
#3079 Epstein Barr virus-encoded LMP1 reprograms glucose metabolism to enha... |
2018 |
| Details |
MOLECULAR AND CELLULAR BIOLOGY / GENETICS: Exploring Oncogenic Transcriptio... |
2018 |
| Details |
#3595 A panel of serum proteins, metabolite and lipid for prognosing prosta... |
2018 |
| Details |
#3843 The potential of heat shock proteins 70/90 as molecular therapeutic t... |
2018 |
| Details |
#4098 New strategy of drug response assessment using PDX organoid platform ... |
2018 |
| Details |
#4350 Integrative and multiregional molecular analysis of localized, high g... |
2018 |
| Details |
#4611 Uterine leiomyoma driver events in uterine adenomyomas.... |
2018 |
| Details |
#4874 Receptor pharmacology and anti-cancer activity of selective DRD2/3 an... |
2018 |
| Details |
#5139 F. nucleatum induces invasive phenotypes in oral cancer cells in vit... |
2018 |
| Details |
#5403 Discovery of high metastatic potential microRNAs in human colo- recta... |
2018 |
| Details |
#5668 The rational design and evaluation of a peptide inhibitor of the PD-1... |
2018 |
| Details |
#5922 Gammora: Selective killing of cancer cells bearing CD24 by viral inte... |
2018 |
| Details |
#237 The genetic architecture of African esophageal cancer.... |
2018 |
| Details |
#498 Dual functions of miR-200b in triple-negative breast cancer metas- tas... |
2018 |
| Details |
#764 GSTP1 knockdown and inhibition impairs pancreatic ductal adeno- carcin... |
2018 |
| Details |
#1016 Transcriptomic analysis of bulk tissues of large PDX collection as a ... |
2018 |
| Details |
#1274 Effects of diet on lung adenoma carcinogenesis in metformin treated A... |
2018 |
| Details |
#1548 Genetic biomarkers predict clinical response and survival in myel- od... |
2018 |
| Details |
#1797 Characterization of a novel androgen receptor coregulator RIPK1.... |
2018 |
| Details |
#2047 N -glycosylation modulates endothelial cell receptor tyrosine kinase ... |
2018 |
| Details |
#2309 Increase in Cdk4 activity during progression of small intestinal neur... |
2018 |
| Details |
#2565 EBV peptide-derived vaccine signifcantly enhanced in vitro cyto- toxi... |
2018 |
| Details |
#2825 PIN1-SCF FBW7 proteolytic signaling regulates the Fanconi anemia pat... |
2018 |
| Details |
#3080 Chronic exposure to arsenic induces malignant transformation in human... |
2018 |
| Details |
#3335 Characterizing the MAX H28R secretome in endometrial cancer.... |
2018 |
| Details |
#3596 Biomarkers of response to CDK4/6 inhibitor (CDK4/6i) in hor- mone rec... |
2018 |
| Details |
#3844 TAK-659, a SYK kinase inhibitor, demonstrates preclinical antitu- mor... |
2018 |
| Details |
#4099 Novelpatient-derived3D(PD3D)cellmodelsandmatchedpatient- derived xeno... |
2018 |
| Details |
#4351 Intratumoral heterogeneity and process of evolution of intrahe- patic... |
2018 |
| Details |
#4612 SET overexpression is associated with recurrence-free survival in pat... |
2018 |
| Details |
#4875 Addition of RP10107, a novel and potent glutaminase inhibitor, accent... |
2018 |
| Details |
#5140 Lipoxins and their role in Kaposis sarcoma-associated herpesvirus (KS... |
2018 |
| Details |
#5404 RNA sequencing-based discovery and validation of a noninvasive microR... |
2018 |
| Details |
transgenic mouse model to assess anti-tumor effcacy of human T-cell-redire... |
2018 |
| Details |
#5923 CD133-targeted oncolytic adenovirus exhibits anti-tumor effect in col... |
2018 |
| Details |
#238 Interactionanalysisbetweengermlinesusceptibilitylociandsomatic alterat... |
2018 |
| Details |
#499 MicroRNA-411 downregulation promotes tumorigenesis and inhib- its chem... |
2018 |
| Details |
#765 Multiple signalling pathways are active in BRAF/NRAS wild type melanom... |
2018 |
| Details |
#1017 Vinorelbine, cyclophosphamide, and 5-FU effects on the circulat- ing ... |
2018 |
| Details |
#1275 A role for FGF2 in visceral adiposity-associated mammary epithe- lial... |
2018 |
| Details |
#1549 LAPTM5 in clear cell renal cell carcinoma.... |
2018 |
| Details |
#1798 A detailed comparison between second-generation AR antagonists reveal... |
2018 |
| Details |
#2049 HNSCC-derived exosomes promote angiogenesis and tumor pro- gression t... |
2018 |
| Details |
#2310 Targeting transcription-associated CDKs is an effective way to combat... |
2018 |
| Details |
#2566 A TCL1-specifc T-cell receptor redirects T cells against B-cell lymph... |
2018 |
| Details |
#2826 Differential activity of ATR and WEE1 inhibitors in DLBCL sub- types ... |
2018 |
| Details |
#3081 Methylation changes and somatic mutations as early events in Lynch sy... |
2018 |
| Details |
#3336 ARID5B activates the TAL1-induced core regulatory circuit and the onc... |
2018 |
| Details |
#3597 Xenobiotic detoxifcation enzymes and cancer risk: A multiplex immunof... |
2018 |
| Details |
breastcancer invivo .... |
2018 |
| Details |
TUMOR BIOLOGY: Molecular Imaging: Novel Probes and Preclinical Studies #410... |
2018 |
| Details |
#4352 High caveolin-1 expression in African American women with early- stag... |
2018 |
| Details |
#4613 The difference of molecular signatures in left- and right-sided colo-... |
2018 |
| Details |
#4877 Allosteric inhibition of SHP2 variants containing cancer-associ- ated... |
2018 |
| Details |
#5141 Streptococcus gallolyticus in colorectal cancer development.... |
2018 |
| Details |
#5405 Multiplex profling of miRNA biomarkers for discovery and verif- catio... |
2018 |
| Details |
#5670 Systemic lymphoid architecture response assessment (SYLARAS): Applica... |
2018 |
| Details |
#5924 Priming tumor cells by immunogenic modulation to enhance IL-27 immune... |
2018 |
| Details |
#239 Development of DNA chip for detection of predictive SNPs for gemcit- a... |
2018 |
| Details |
#500 A p53/miR-30a/ZEB2 axis controls basal-like/triple-negative breast can... |
2018 |
| Details |
#766 Refractory and relapsed predictive biomarkers in Hodgkin lym- phoma an... |
2018 |
| Details |
#1019 EphA2 receptor tyrosine kinase regulates programmed death li- gand 2 ... |
2018 |
| Details |
#1276 Differentiation of human colon adenomas in an enteroid culture: A tre... |
2018 |
| Details |
#1550 Limb-bud and heart inhibits the proliferation and metastasis of human... |
2018 |
| Details |
#1799 ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tu- mors are a di... |
2018 |
| Details |
#2050 Tumor stage-dependent transcriptomic signatures of endothelial cells ... |
2018 |
| Details |
#2311 Determinants of CDK4 target engagement by palbociclib, riboci- clib a... |
2018 |
| Details |
#2567 Novel therapeutic interventions to alleviate CAR T cell-induced cytok... |
2018 |
| Details |
#2827 Alternative non-homologous end joining DNA repair as therapeu- tic ta... |
2018 |
| Details |
#3082 Epidermal-specifc overexpression of T-cell protein tyrosine phos- pha... |
2018 |
| Details |
heterodimer formation in hypoxic TNBC cells.... |
2018 |
| Details |
#3598 Classifcation of the collagen ECM in normal human tissue as a biomark... |
2018 |
| Details |
#3846 A metabolic pathway targeted inhibitor for precision therapy of castr... |
2018 |
| Details |
TUMOR BIOLOGY: Mechanisms and Models of Gastrointestinal Malignancies... |
2018 |
| Details |
#4353 Integrated molecular analysis of upper urinary tract urothelial car- ... |
2018 |
| Details |
#4614 Molecular subtypes in muscle invasive bladder cancer: Evaluation of c... |
2018 |
| Details |
#4878 RMC-4550, an allosteric inhibitor of SHP2: Synthesis, structure, and ... |
2018 |
| Details |
#5142 Elevated glycolysis in pre-malignant ovarian cancer.... |
2018 |
| Details |
#5406 Predictive value of tumor microRNAs in head and neck cancer pa- tient... |
2018 |
| Details |
#5671 Humanized mouse models for evaluation of cancer therapies.... |
2018 |
| Details |
#5925 A novel oncolytic adenovirus for radioiodine therapy and imaging.... |
2018 |
| Details |
#240 SNP-mediated repression of DCBLD1 by YY1 may explain a GWAS fnding on ... |
2018 |
| Details |
MOLECULAR AND CELLULAR BIOLOGY / GENETICS: Noncoding RNAs as Oncogenes and ... |
2018 |
| Details |
#767 Identifcation of cell surface proteins expressed exclusively on mu- ta... |
2018 |
| Details |
#1020 Characterization of the immune landscape and analysis of tumor respon... |
2018 |
| Details |
#1277 3-Isothiocyanato-1-propene as biomodulatory agent in ameliorat- ing p... |
2018 |
| Details |
#1551 Determination of the origin of oral squamous cell carcinoma by microa... |
2018 |
| Details |
#1800 Progesterone receptor attenuates STAT1-mediated interferon sig- nalin... |
2018 |
| Details |
#2051 Perfusable 3D angiogenesis in a high-throughput microfluidic cul- tur... |
2018 |
| Details |
#2312 Phospho-proteomics analysis to determine the signaling pathways affec... |
2018 |
| Details |
#2568 CAR T cells secreting an immune checkpoint blockade scFv have enhance... |
2018 |
| Details |
#2828 MMR status affects effciency of homologous recombination re- pair of ... |
2018 |
| Details |
#3083 Ameliorative effect of ethanolic extract of Annona muricata against... |
2018 |
| Details |
#3338 BP1 induces an epithelial to mesenchymal transition in breast can- ce... |
2018 |
| Details |
#3599 Novel and established acute myeloid leukemia (AML) subsets cor- relat... |
2018 |
| Details |
#3848 Functionalized small-molecule thiosemicarbazones as inhibitors of cat... |
2018 |
| Details |
#4102 Surgical imaging of pancreatic cancer using near infrared fluores- ce... |
2018 |
| Details |
#4354 Molecular signature of multiple myeloma progression through sin- gle-... |
2018 |
| Details |
#4615 Phenotypic subtypes successfully stratify prognosis of patient with c... |
2018 |
| Details |
#4879 Mutation selectivity of the allosteric SHP2 inhibitor SHP099.... |
2018 |
| Details |
#5143 Characterization of the cervicovaginal, endometrial and anorectal mic... |
2018 |
| Details |
#5407 MicroRNA expression analysis of advanced colorectal cancer re- veals ... |
2018 |
| Details |
#5672 Facile generation of single-cell transcriptome and immune reper- toir... |
2018 |
| Details |
#5927 Assessing the effcacy of a novel gene therapy approach for treating o... |
2018 |
| Details |
#241 Contribution of female breast cancer predisposition SNPs to risk of ma... |
2018 |
| Details |
#502 Circulating exosomal miR-203 is associated with metastasis via in- duc... |
2018 |
| Details |
#768 Identifcation of signal transduction pathways specifc for mutant KRas-... |
2018 |
| Details |
#1021 Clinical signifcance of tertiary lymphoid structures (TLS) and tu- mo... |
2018 |
| Details |
PREVENTION RESEARCH: Molecular Mechanisms and Targets for Cancer Prevention... |
2018 |
| Details |
#1552 SATB1 is a novel prognostic factor in esophageal cancer patients and... |
2018 |
| Details |
#1802 Constitutively active androgen receptor splice variants AR-V3, AR-V7 ... |
2018 |
| Details |
#2052 A novel PHD2/VHL-mediated regulation of YAP1 and its role in vascular... |
2018 |
| Details |
#2313 Effect of dinaciclib on drug-naive and letrozole- and palbociclib- re... |
2018 |
| Details |
#2569 CAR19 T cells secreting antigen-retargeting fusion proteins have rema... |
2018 |
| Details |
#2829 Targeting the DNA damage response and DNA-PK signaling via small mole... |
2018 |